<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Behav Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Behav Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Behav. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Behavioral Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1662-5153</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24109443</article-id><article-id pub-id-type="pmc">3791382</article-id><article-id pub-id-type="doi">10.3389/fnbeh.2013.00138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Original Research Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Porchet</surname><given-names>Roseline I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boekhoudt</surname><given-names>Linde</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Studer</surname><given-names>Bettina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gandamaneni</surname><given-names>Praveen K.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rani</surname><given-names>Nisha</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Binnamangala</surname><given-names>Somashekar</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Ulrich</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Clark</surname><given-names>Luke</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Psychology, University of Cambridge</institution><country>Cambridge, UK</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Psychology, Behavioural and Clinical Neuroscience Institute, University of Cambridge</institution><country>Cambridge, UK</country></aff><aff id="aff3"><sup>3</sup><institution>Institute of Cognitive Neuroscience, University College London</institution><country>London, UK</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Psychiatry, University of Cambridge</institution><country>Cambridge, UK</country></aff><aff id="aff5"><sup>5</sup><institution>Cambridgeshire and Peterborough NHS Foundation Trust</institution><country>Cambridge, UK</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Bryan F. Singer, University of Michigan, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Martin Zack, Centre for Addiction and Mental Health, Canada; Harriet De Wit, University of Chicago, USA</p></fn><corresp id="fn001">*Correspondence: Luke Clark, Department of Psychology, University of Cambridge, Downing Street, Cambridge CB2 3EB, Cambridge, UK e-mail: <email xlink:type="simple">lc260@cam.ac.uk</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to the journal Frontiers in Behavioral Neuroscience.</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="collection"><year>2013</year></pub-date><volume>7</volume><elocation-id>138</elocation-id><history><date date-type="received"><day>10</day><month>7</month><year>2013</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Porchet, Boekhoudt, Studer, Gandamaneni, Rani, Binnamangala, M&#x000fc;ller and Clark.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Gambling is characterized by cognitive distortions in the processing of chance and skill that are exacerbated in pathological gambling. Opioid and dopamine dysregulation is implicated in pathological gambling, but it is unclear whether these neurotransmitters modulate gambling distortions. The objective of the current study was to assess the effects of the opioid receptor antagonist naltrexone and the dopamine D2 receptor antagonist haloperidol on gambling behavior. Male recreational gamblers (<italic>n</italic> = 62) were assigned to receive single oral doses of naltrexone 50 mg, haloperidol 2 mg or placebo, in a parallel-groups design. At 2.5 h post-dosing, participants completed a slot machine task to elicit monetary wins, &#x0201c;near-misses,&#x0201d; and a manipulation of personal choice, and a roulette game to elicit two biases in sequential processing, the gambler's fallacy and the hot hand belief. Psychophysiological responses (electrodermal activity and heart rate) were taken during the slot machine task, and plasma prolactin increase was assessed. The tasks successfully induced the gambling effects of interest. Some of these effects differed across treatment groups, although the direction of effect was not in line with our predictions. Differences were driven by the naltrexone group, which displayed a greater physiological response to wins, and marginally higher confidence ratings on winning streaks. Prolactin levels increased in the naltrexone group, but did not differ between haloperidol and placebo, implying that naltrexone but not haloperidol may have been functionally active at these doses. Our results support opioid modulation of cognition during gambling-like tasks, but did not support the more specific hypothesis that naltrexone may act to ameliorate cognitive distortions.</p></abstract><kwd-group><kwd>naltrexone</kwd><kwd>haloperidol</kwd><kwd>pathological gambling</kwd><kwd>addiction</kwd><kwd>reward</kwd><kwd>motivation</kwd><kwd>decision-making</kwd><kwd>psychophysiology</kwd></kwd-group><counts><fig-count count="6"/><table-count count="3"/><equation-count count="0"/><ref-count count="106"/><page-count count="13"/><word-count count="11415"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Gambling is a widespread form of recreational risk-taking that becomes excessive and pathological in a subset of the population (around 1%; Wardle et al., <xref ref-type="bibr" rid="B94">2010</xref>). Pathological gambling is increasingly viewed as a &#x0201c;behavioral addiction&#x0201d; and has been reclassified within the Addictions category in the DSM-5 (Petry et al., <xref ref-type="bibr" rid="B77">2013</xref>). Recent work on pathological gambling has studied its underlying neurobiological basis, highlighting the similarities with substance use disorders (Potenza, <xref ref-type="bibr" rid="B80">2008</xref>) and focusing on the neuroimaging of reward-based tasks (Limbrick-Oldfield et al., <xref ref-type="bibr" rid="B55">2013</xref>) and changes in neurotransmitter function (Leeman and Potenza, <xref ref-type="bibr" rid="B54">2012</xref>). A distinct cognitive approach to gambling has emphasized the role of erroneous thinking styles (&#x0201c;cognitive distortions&#x0201d;) during gambling (Ladouceur and Walker, <xref ref-type="bibr" rid="B50">1996</xref>; Clark, <xref ref-type="bibr" rid="B13">2010</xref>): gamblers experience a variety of biases and erroneous thoughts during play, pertaining in particular to their perceived level of skill in controlling the outcomes (&#x0201c;the illusion of control&#x0201d;; Langer, <xref ref-type="bibr" rid="B51">1975</xref>) and their tendency to detect patterns in random sequences (&#x0201c;the Gambler's Fallacy&#x0201d;; Oskarsson et al., <xref ref-type="bibr" rid="B73">2009</xref>). While the gambling cognitions are apparent in non-problem gamblers and student populations, the overall level of distorted thinking is elevated in people with gambling problems (Miller and Currie, <xref ref-type="bibr" rid="B63">2008</xref>; Emond and Marmurek, <xref ref-type="bibr" rid="B29">2010</xref>; Michalczuk et al., <xref ref-type="bibr" rid="B62">2011</xref>) and these cognitions can be targeted effectively by cognitive-behavioral therapies (Fortune and Goodie, <xref ref-type="bibr" rid="B30">2012</xref>). The neurobiological mechanisms that underlie these gambling-related distortions have received minimal attention to date, and the aim of the present study was to examine their pharmacological basis, looking at dopamine and opioid receptor manipulations, in a sample of mild recreational gamblers.</p><p>The opioid system is the target of growing interest in pathological gambling, primarily on the basis of clinical trials showing significant benefits of the opioid receptor antagonists naltrexone and nalmefene on gambling symptom severity and self-reported craving (Kim et al., <xref ref-type="bibr" rid="B46">2001</xref>; Grant et al., <xref ref-type="bibr" rid="B38">2006</xref>, <xref ref-type="bibr" rid="B37">2008</xref>). These medications are well established in the clinical management of opiate and alcohol dependence (O'Brien, <xref ref-type="bibr" rid="B70">2005</xref>). Preclinical evidence indicates that opioid receptors are distributed widely in the mesolimbic system, and can modulate dopamine transmission (Spanagel et al., <xref ref-type="bibr" rid="B87">1992</xref>). Endogenous opioids are implicated particularly in hedonic aspects of reward processing (Pecina et al., <xref ref-type="bibr" rid="B74">2006</xref>; Barbano and Cador, <xref ref-type="bibr" rid="B3">2007</xref>). Of relevance to gambling behavior, a pharmacological fMRI study of the &#x003bc;-opioid antagonist naloxone found attenuated reward-related responses in the ventral striatum, and enhanced loss-related activity in the medial prefrontal cortex, on a wheel of fortune task in healthy volunteers (Petrovic et al., <xref ref-type="bibr" rid="B76">2008</xref>). Thus, the treatment effect in pathological gambling may be mediated by a dual action of enhancing aversive processing and attenuating positive processing of gambling outcomes. The present study employed the opioid receptor antagonist naltrexone, which is a competitive antagonist at &#x003bc;- and &#x003ba;-opioid receptors, and to a lesser extent at &#x003b4;-opioid receptors (Kreek, <xref ref-type="bibr" rid="B47">1996</xref>). We used a 50 mg single dose that is widely used in other cognitive studies in healthy volunteers (Katzen-Perez et al., <xref ref-type="bibr" rid="B45">2001</xref>; Mitchell et al., <xref ref-type="bibr" rid="B66">2007</xref>; Boettiger et al., <xref ref-type="bibr" rid="B8">2009</xref>).</p><p>Dopamine dysregulation has also been indicated in problem gambling, based on genetic data (Lobo and Kennedy, <xref ref-type="bibr" rid="B57">2009</xref>) and studies measuring peripheral markers (Bergh et al., <xref ref-type="bibr" rid="B5">1997</xref>; Meyer et al., <xref ref-type="bibr" rid="B60">2004</xref>), as well as the provocative syndrome in Parkinson's Disease where medications acting at the dopamine D2/D3-receptor are linked to the emergence of disordered gambling as a side-effect (Voon et al., <xref ref-type="bibr" rid="B93">2009</xref>; Djamshidian et al., <xref ref-type="bibr" rid="B25">2011</xref>). Dynamic PET studies with the dopamine D2/D3 radiotracer [11C]raclopride have confirmed that monetary reinforcement induces dopamine release in healthy volunteers performing gambling-like tasks (Zald et al., <xref ref-type="bibr" rid="B101">2004</xref>; Martin-Soelch et al., <xref ref-type="bibr" rid="B59">2011</xref>), and the magnitude of dopamine release is elevated in at least a subset of patients with pathological gambling (Steeves et al., <xref ref-type="bibr" rid="B88">2009</xref>; Linnet et al., <xref ref-type="bibr" rid="B56">2011</xref>; Joutsa et al., <xref ref-type="bibr" rid="B42">2012</xref>). In addition, acute administration of the dopamine stimulant amphetamine, and the D2-receptor antagonist haloperidol, were both seen to modulate gambling tendencies in pathological gamblers (Zack and Poulos, <xref ref-type="bibr" rid="B98">2004</xref>, <xref ref-type="bibr" rid="B99">2007</xref>). In the present study, we sought to manipulate dopamine transmission with haloperidol, a first generation antipsychotic with high D2 binding affinity in the striatum (Kapur et al., <xref ref-type="bibr" rid="B43">1996</xref>; Xiberas et al., <xref ref-type="bibr" rid="B97">2001</xref>). We selected a low (2 mg) dose of haloperidol that we expected to act preferentially on the presynaptic D2 auto-receptors to <italic>increase</italic> dopamine transmission (Frank and O'Reilly, <xref ref-type="bibr" rid="B31">2006</xref>).</p><p>We examined a number of gambling variables that can be elicited with laboratory tasks. We used a slot machine task that delivered unpredictable monetary wins as well as &#x0201c;near-miss&#x0201d; outcomes: non-wins that are spatially proximal to a jackpot win (Reid, <xref ref-type="bibr" rid="B84">1986</xref>). Relative to &#x0201c;full-misses,&#x0201d; near-misses are rated as unpleasant but increase motivations to continue gambling, despite their objective non-win status (see also Kassinove and Schare, <xref ref-type="bibr" rid="B44">2001</xref>). Previous neuroimaging of this task showed that near-misses recruited overlapping brain circuitry to the win outcomes, including the ventral striatum and insula, in both healthy volunteers and regular gamblers (Clark et al., <xref ref-type="bibr" rid="B16">2009</xref>; Chase and Clark, <xref ref-type="bibr" rid="B12">2010</xref>). In the present study, we measured the subjective response to these wins and near-misses with trial-by-trial ratings. We also recorded psychophysiological activity following these outcomes using electrodermal activity (EDA) and heart rate (HR) recording, which have established sensitivity to gambling outcomes (Dixon et al., <xref ref-type="bibr" rid="B24">2011</xref>; Lole et al., <xref ref-type="bibr" rid="B58">2012</xref>; Studer and Clark, <xref ref-type="bibr" rid="B90">2011</xref>; Clark et al., <xref ref-type="bibr" rid="B14">2012a</xref>). In addition, the slot machine task measures one example of illusory control, the effect of personal choice, by comparing the expectancies of winning under conditions where the participant either chose, or was not able to choose, the &#x0201c;play icon.&#x0201d; Subjects rate their expectancy of winning as higher on participant-chosen trials (Clark et al., <xref ref-type="bibr" rid="B16">2009</xref>, <xref ref-type="bibr" rid="B14">2012a</xref>), and fMRI signals to monetary wins are enhanced under this choice manipulation (Coricelli et al., <xref ref-type="bibr" rid="B18">2005</xref>; Studer et al., <xref ref-type="bibr" rid="B89">2012</xref>).</p><p>We also administered a second task, based upon roulette, which involved binary predictions of red or black outcomes and a subsequent confidence rating (Ayton and Fischer, <xref ref-type="bibr" rid="B2">2004</xref>). The Gambler's Fallacy is observed as the reduced choice of one color (e.g., red) after a &#x0201c;run&#x0201d; of consecutive outcomes of that color (e.g., four successive reds). In addition, participant's confidence ratings are sensitive to their prediction accuracy, with &#x0201c;streaks&#x0201d; of consecutive correct guesses (i.e., wins) increasing self-reported confidence, and incorrect predictions (i.e., a losing streak) leading to decreased confidence. These are known as &#x0201c;hot hand&#x0201d; effects (Gilovich et al., <xref ref-type="bibr" rid="B34">1985</xref>; Ayton and Fischer, <xref ref-type="bibr" rid="B2">2004</xref>). Past neuroimaging studies found modulation of caudate, insula and medial prefrontal cortex activity by streaks of wins and losses in binary choice games (Elliott et al., <xref ref-type="bibr" rid="B28">2000</xref>; Akitsuki et al., <xref ref-type="bibr" rid="B1">2003</xref>).</p><p>As a preliminary investigation, we examined the effects of haloperidol and naltrexone on these gambling variables in a group of healthy male volunteers, who reported recreational gambling involvement. There is evidence that both gambling-related cognitive distortions, and problem gambling symptom severity, exist on a continuum, such that recreational gamblers are considered at some degree of risk for later problematic gambling (Toce-Gerstein et al., <xref ref-type="bibr" rid="B91">2003</xref>; Raylu and Oei, <xref ref-type="bibr" rid="B82">2004</xref>). Rates of gambling involvement and the prevalence of pathological gambling are typically higher in males (Bland et al., <xref ref-type="bibr" rid="B7">1993</xref>; Shaffer et al., <xref ref-type="bibr" rid="B85">1999</xref>).</p><p>The overarching hypothesis was that the gambling cognitions under scrutiny would be modulated by the dopamine and opioid-based treatments. Given preclinical evidence that &#x003bc;-opioid blockade exerts a downstream effect on dopamine transmission (Spanagel et al., <xref ref-type="bibr" rid="B87">1992</xref>), we were further interested in the overlap between the cognitive variables affected by naltrexone and haloperidol. Previous work afforded a number of more specific predictions. First, there are some indications that dopamine may modulate near-miss effects and illusory control, specifically. Using a rodent version of a slot machine, amphetamine and the dopamine D2 agonist quinpirole increased erroneous lever presses on a game with near-misses (2 of 3 identical symbols) (Winstanley et al., <xref ref-type="bibr" rid="B96">2011</xref>). Dopamine is also implicated in perceptions of control (Declerck et al., <xref ref-type="bibr" rid="B23">2006</xref>; Redgrave and Gurney, <xref ref-type="bibr" rid="B83">2006</xref>); for example, levodopa increased the sense of agency (&#x0201c;action-effect binding&#x0201d;) on a timing task in patients with Parkinson's Disease (Moore et al., <xref ref-type="bibr" rid="B67">2010</xref>). As such, we predicted that the low dose of haloperidol would potentiate subjective and physiological responses to win and near-miss outcomes, and enhance the influence of personal choice, on the slot machine task. Second, drawing on Petrovic et al. (<xref ref-type="bibr" rid="B76">2008</xref>), we predicted that the naltrexone group would show attenuated responses to winning outcomes, coupled with enhanced negative processing (affect following near-misses) on the two tasks. Given the lack of past work to guide predictions about neurotransmitter effects on the Roulette task, these data were analyzed in an exploratory manner.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec><title>Participants</title><p>Male participants (<italic>n</italic> = 62) were recruited through the University and community advertisements. Participants were aged 18&#x02013;49 years, and reported past year gambling involvement and at least 5 lifetime gambling experiences. Exclusion criteria (confirmed through telephone interview): a score = 8 (indicative of probable pathological gambling) on the Problem Gambling Severity Index (Ferris and Wynne, <xref ref-type="bibr" rid="B103">2001</xref>), significant neurological or physical illness, current or past mental health problems, including substance use and heavy smoking (&#x0003e;10 cigarettes/day). The study was approved by the Cambridgeshire 4 Research Ethics Committee (10/H0305/79). All participants gave written informed consent and were paid &#x000a3;35 for their participation (plus a task-related bonus of &#x000a3;6).</p></sec><sec><title>Study design</title><p>The study was a double-blind, parallel-groups, placebo-controlled design, involving a single session at a clinical research facility. Subjects were randomly allocated to the three treatment groups: 2 mg haloperidol, 50 mg naltrexone or placebo (microcritalline cellulose) hidden in identical gelatine capsules. Upon arrival, a urine sample was taken to confirm absence of recent opiate use, and participants completed trait questionnaires assessing impulsivity (UPPS-P; Cyders et al., <xref ref-type="bibr" rid="B104">2007</xref>) and susceptibility to gambling biases (Gambling Related Cognition Scale; Raylu and Oei, <xref ref-type="bibr" rid="B82">2004</xref>). Participants also completed the electronic Mini International Neuropsychiatric Interview (eMINI) (Sheehan et al., <xref ref-type="bibr" rid="B105">1998</xref>) for further investigation of current and lifetime psychiatric disorders. Mental health problems were detected in 17 participants; 7 subjects in the placebo group (alcohol dependence <italic>n</italic> = 4, obsessive-compulsive disorder <italic>n</italic> = 1, hypomanic episode <italic>n</italic> = 1, bulimia nervosa <italic>n</italic> = 1), 7 subjects in the haloperidol group (alcohol dependence <italic>n</italic> = 1, alcohol abuse <italic>n</italic> = 2, obsessive-compulsive disorder <italic>n</italic> = 2, cocaine abuse <italic>n</italic> = 1, generalized anxiety disorder <italic>n</italic> = 1); and 3 subjects in the naltrexone group (alcohol dependence <italic>n</italic> = 1, hypomanic episode <italic>n</italic> = 1, major depressive episode <italic>n</italic> = 1). The proportion of participants meeting eMINI diagnoses did not differ across the three treatment groups (&#x003c7;<sup>2</sup> = 2.77, <italic>p</italic> = 0.25). Given that participants had disclosed no past or current mental health problems in the telephone interviews, we cannot rule out the possibility that the eMINI detections were false positives.</p><p>Following dosing, participants rested for 2.5 h to allow drug absorption. This timing was based upon pharmacokinetic data showing that haloperidol reaches maximal plasma concentrations after 3 h (plasma half-life: 24 h) (Darby et al., <xref ref-type="bibr" rid="B20">1995</xref>), whereas naltrexone reaches maximal plasma concentration after 45 min with a plasma half-life of 4 h (Crabtree, <xref ref-type="bibr" rid="B19">1984</xref>; Meyer et al., <xref ref-type="bibr" rid="B61">1984</xref>). After this rest period, volunteers completed the Slot Machine Task (Clark et al., <xref ref-type="bibr" rid="B16">2009</xref>) with concurrent psychophysiological monitoring of HR and EDA, followed by the Roulette Task (Ayton and Fischer, <xref ref-type="bibr" rid="B2">2004</xref>). Blood samples were taken pre-dosing (T1) and at the start of the testing period (T2, +2.5 h) to measure serum prolactin levels as a marker of dopaminergic tone (Ben-Jonathan and Hnasko, <xref ref-type="bibr" rid="B4">2001</xref>). Blood pressure (BP) and HR were measured with a wrist cuff, and mood was measured with Visual Analogue Scales (Bond and Lader, <xref ref-type="bibr" rid="B106">1974</xref>), at T1, T2, and on completion of testing (T3, +4 h). VAS data were unavailable for a single subject.</p></sec><sec><title>Prolactin analysis</title><p>Blood samples (4.7 ml) were centrifuged at 4000 rpm for 5 min at room temperature to obtain serum and then distributed into two aliquots of about 1.5 ml. The samples were frozen at &#x02212;80&#x000b0;C until analysis. Prolactin levels were analyzed by the National Institute for Health Research Cambridge Biomedical Research Center Core Biochemistry Assay Laboratory, Addenbrooke's hospital, and were tested with immunofluorometric assay (ADVIA Centaur prolactin assay, Siemens). Results are reported in mU/L. Prolactin samples were unavailable or contaminated by macroprolactin in two subjects.</p></sec><sec><title>Tasks</title><sec><title>Slot machine task</title><p>Participants completed 60 trials (following 4 practice trials) on a simplified two-reel slot machine task, described in detail in Clark et al. (<xref ref-type="bibr" rid="B16">2009</xref>) (see Figure <xref ref-type="fig" rid="F1">1</xref>). Psychophysiological signals (EDA and HR) were monitored during the task using a Biopac MP36 (see below). The screen background color (white or black) designated two choice conditions: either participant-chosen trials, in which the participant selected the &#x0201c;play icon&#x0201d; on the left reel by scrolling the reel up or down, and computer-chosen trials, in which the play icon was selected automatically. Following icon selection, the right reel spun and decelerated (mean spin time: 4.2 s) to deliver a win (&#x000a3;1), near-miss, or full-miss outcome (outcome duration 6 s). Current earnings were displayed in the inter-trial interval (duration 5 s), with an initial endowment of &#x000a3;5. The outcomes and choice condition (participant-chosen, computer-chosen) occurred in a fixed pseudo-random sequence such that wins occurred on 1/6, and near-misses on 1/3 trials. As a consequence of the fixed sequence, all participants completed the task with &#x000a3;6, which they received as a bonus.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>The slot machine task displayed two reels, with the same six icons on each reel</bold>. Each trial involved a fixed &#x000a3;0.15 p wager. After a selection phase in which either the computer or the participant chose one of the icons on the left reel as the &#x0201c;play icon,&#x0201d; the right reel spun for a variable anticipation phase. The right reel decelerated and came to a standstill. If the right reel stopped on the chosen play icon, i.e., the reels were aligned on the central payline, the subject won &#x000a3;1. If the right reel stopped on a different icon (5/6 trials), the participant lost their wager. In the analysis of these non-wins, we distinguished near-misses (with the play icon either side of the payline) and full-misses (with the play icon more than one position from the payline).</p></caption><graphic xlink:href="fnbeh-07-00138-g0001"/></fig><p>On each trial, three Likert ratings were taken: following icon selection, &#x0201c;How do you rate your chances of winning?&#x0201d; (0 to +100), and following the outcome, &#x0201c;How pleased are you with the result?&#x0201d; (&#x02212;100 to +100) and &#x0201c;How much do you want to continue to play?&#x0201d; (0 to +100).</p></sec><sec><title>Roulette task</title><p>This binary choice task was modified from Ayton and Fischer (<xref ref-type="bibr" rid="B2">2004</xref>). The roulette wheel displayed an equal number of red and blue segments (see Figure <xref ref-type="fig" rid="F2">2</xref>), and on each trial, the participant first guessed red or blue, and then gave a confidence rating on 21-point scale. A history bar during the color choice presented the 10 previous outcomes, to minimize working memory demands that may be independently affected by the drug treatments.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>The roulette task presented a color choice (red or blue) on each trial, followed by a confidence rating</bold>. The roulette wheel then spun, and the outcome and feedback were presented. A history bar across the top of the screen indicated the last ten outcomes, to alleviate any working memory requirements.</p></caption><graphic xlink:href="fnbeh-07-00138-g0002"/></fig><p>Following the color choice and confidence rating, the wheel spun for 800&#x02013;1200 ms, and the outcome was presented (e.g., &#x0201c;Blue: you win&#x0201d;). Participants received &#x000a3;0.10 for correct guesses, with no reinforcement (i.e., losses) for incorrect guesses. Participants completed 3 practice trials, followed by a total of 90 trials, using a pre-specified color sequence in order to deliver runs of 1&#x02013;5 consecutive outcomes of the same color. This fixed sequence had an equal probability of either color, and a probability of alternation of 0.48 (see Oskarsson et al., <xref ref-type="bibr" rid="B73">2009</xref> for derivation). We refer to consecutive outcomes of the same color as &#x0201c;outcome runs&#x0201d; (i.e., blue, red, red, red is an outcome run of length 3), and consecutive correct or incorrect predictions as &#x0201c;feedback streaks.&#x0201d; Two dependent variables were derived: (1) the probability of choosing either color as a function of the outcome run of that color, indicative of the Gambler's Fallacy, (2) the confidence rating as a function of feedback streak, indicative of the Hot Hand Beliefs.</p></sec></sec><sec><title>Psychophysiological measurement</title><p>During the slot machine task, electrodermal activity (EDA) and HR calculated from electrocardiogram (ECG) were recorded via a BIOPAC MP36 unit (BIOPAC Systems Ltd, Goleta, CA, USA), following methods previously (Clark et al., <xref ref-type="bibr" rid="B14">2012a</xref>,<xref ref-type="bibr" rid="B15">b</xref>). The BIOPAC unit, sampling at 1000 Hz, was connected to the stimulus delivery computer and to a second recording computer running AcqKnowledge 4.1 software. Task events were marked on the psychophysiological trace via a parallel port connection. EDA was recorded through fingertip electrodes attached to the index and middle fingers of the non-dominant hand. Heart rate was recorded using ECG electrode patches applied to the right wrist and left ankle. The psychophysiological data were extracted using in-house scripts developed in Microsoft Visual Basic (v6.0): activity on the slot machine task was modeled to the time of outcome delivery, using change from baseline scores calculated from the mean activity in the final 2 s of reel spin. Mean EDA was extracted in 6 &#x000d7; 2 s bins from the onset of the outcome phase. An EDA summary measure was calculated from the maximum change from baseline value in bins 2&#x02013;4 (i.e., 2&#x02013;8 s post-outcome), given the typical time-course for EDA changes (Dawson et al., <xref ref-type="bibr" rid="B22">2000</xref>). HR responses were calculated using the median HR in 12 &#x000d7; 0.5 s bins from the onset of the outcome phase. Two HR summary measures isolated the initial HR deceleration component (the minimum value in bins 1&#x02013;6, i.e., 0&#x02013;3 s post-outcome, minus the baseline) and the subsequent HR acceleration component (the maximum in bins 7&#x02013;12, i.e., 3&#x02013;6 s post-outcome, minus the deceleration minima) (Hodes et al., <xref ref-type="bibr" rid="B40">1985</xref>; Bradley, <xref ref-type="bibr" rid="B9">2000</xref>).</p></sec><sec><title>Statistical analysis</title><p>Statistical analysis was performed in SPSS version 19.0. Demographic and trait variables were compared across groups using One-Way ANOVA. Fisher's least significant difference test was used for <italic>post-hoc</italic> comparisons, as is appropriate for 3-group designs (Cardinal and Aitken, <xref ref-type="bibr" rid="B10">2006</xref>). Mood scales, cardiovascular measures, and prolactin levels were assessed with mixed-model ANOVAs including Timepoint as a within-subjects factor.</p><p>On the slot machine task, the subjective ratings and psychophysiology summary measures were analyzed with mixed-model ANOVA, with Outcome (wins, near-misses, full-misses) and Choice (participant-chosen, computer-chosen) as within-subjects factors, and Treatment (3 levels: haloperidol, naltrexone, placebo) as a between-subjects factors. Data from the roulette task were analyzed using two mixed-model ANOVAs, with Treatment (3 levels: placebo, haloperidol, naltrexone) as the between-subjects factor. For analysis of color predictions, Outcome Run length was the within-subjects factor. For the analysis of confidence ratings, Feedback Streak length and Outcome (winning, losing) were within-subjects factors. Simple main effects analysis of the roulette task data compared shorter runs/streaks (1&#x02013;2 successive events) against longer runs/streaks (4&#x02013;5 successive events). As the feedback streaks were not pre-specified, some subjects did not experience any longer streaks. For participants missing only streaks of length five, we imputed their streak length 4 value for their missing value (this is a conservative approach that underestimates any effect of the longer streaks). Three participants were excluded who did not experience streaks longer than three events. In addition, one further participant was excluded who did not vary either his color choice or confidence ratings across the task.</p><p>As the primary aim of this study was to compare the effects of haloperidol and naltrexone relative to the placebo condition, rather than the direct comparison of the two active treatments, the omnibus 3-group model was decomposed using two planned comparisons of the haloperidol group vs. placebo, and the naltrexone group vs. placebo. For all analyses, the Greenhouse-Geisser correction was applied when sphericity assumptions were violated, and the Huynh-Feldt correction was reported when the Greenhouse-Geisser estimate was greater than 0.75 (Cardinal and Aitken, <xref ref-type="bibr" rid="B10">2006</xref>). All tests were thresholded at <italic>p</italic> &#x0003c; 0.05 two-tailed.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>The three treatment groups did not differ significantly in age, years of education, trait gambling distortions, or impulsivity (see Table <xref ref-type="table" rid="T1">1</xref>). The overall level of problem gambling was low on the PGSI (mean 1.5; <italic>SD</italic> 1.73; range 0&#x02013;7; a score = 8 is indicative of probable pathological gambling), but GRCS scores were in range of previous data in recreational gamblers (Raylu and Oei, <xref ref-type="bibr" rid="B82">2004</xref>; Billieux et al., <xref ref-type="bibr" rid="B6">2012</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Participant characteristics and demographic details</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><bold>Placebo</bold></th><th align="left" rowspan="1" colspan="1"><bold>Haloperidol</bold></th><th align="left" rowspan="1" colspan="1"><bold>Naltrexone</bold></th><th align="left" rowspan="1" colspan="1"><bold>Test statistic</bold></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><bold>(<italic>N</italic> = 20)</bold></th><th align="left" rowspan="1" colspan="1"><bold>(<italic>N</italic> = 21)</bold></th><th align="left" rowspan="1" colspan="1"><bold>(<italic>N</italic> = 21)</bold></th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="char" char="." rowspan="1" colspan="1">27.2 (8.0)</td><td align="char" char="." rowspan="1" colspan="1">26.6 (7.1)</td><td align="char" char="." rowspan="1" colspan="1">27.1 (8.3)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(2, 61)</sub> = 0.04, NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Education</td><td align="char" char="." rowspan="1" colspan="1">17.4 (3.1)</td><td align="char" char="." rowspan="1" colspan="1">16.3 (3.1)</td><td align="char" char="." rowspan="1" colspan="1">16.7 (2.3)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(2, 61)</sub> = 0.68, NS</td></tr><tr><td align="left" rowspan="1" colspan="1">PGSI</td><td align="char" char="." rowspan="1" colspan="1">1.6 (1.7)</td><td align="char" char="." rowspan="1" colspan="1">1.6 (1.8)</td><td align="char" char="." rowspan="1" colspan="1">1.3 (1.8)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(2, 61)</sub> = 0.17, NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GRCS</td><td align="char" char="." rowspan="1" colspan="1">47.7 (21.2)</td><td align="char" char="." rowspan="1" colspan="1">53.4 (15.1)</td><td align="char" char="." rowspan="1" colspan="1">58.0 (18.1)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(2, 61)</sub> = 1.64, NS</td></tr><tr><td align="left" rowspan="1" colspan="1">UPPS-P</td><td align="char" char="." rowspan="1" colspan="1">137.8 (17.8)</td><td align="char" char="." rowspan="1" colspan="1">128.3 (23.4)</td><td align="char" char="." rowspan="1" colspan="1">129.2 (14.6)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(2, 61)</sub> = 1.57, NS</td></tr></tbody></table><table-wrap-foot><p>The values are reported in means and standard deviations; PGSI, problem gambling severity index (range 0&#x02013;27); GRCS, gambling-related cognitions scale (range 23&#x02013;161), UPPS-P Impulsivity Scale (range 59&#x02013;236). NS, not significant.</p></table-wrap-foot></table-wrap><sec><title>Prolactin levels</title><p>For plasma prolactin levels, there was a significant Treatment &#x000d7; Time interaction [<italic>F</italic><sub>(2, 57)</sub> = 4.09, <italic>p</italic> = 0.022, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.13]. The main effects of Treatment [<italic>F</italic><sub>(2, 57)</sub> = 2.42, <italic>p</italic> = 0.098, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.08] and Time [<italic>F</italic><sub>(1, 57)</sub> = 3.44, <italic>p</italic> = 0.069, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.06] approached significance. Analysis of change scores (T2 minus T1) indicated prolactin increase in the naltrexone group compared to placebo [<italic>t</italic><sub>(38)</sub> = &#x02212;2.78, <italic>p</italic> = 0.008], consistent with downstream dopaminergic blockade by naltrexone. The haloperidol group did not differ significantly from placebo (<italic>p</italic> &#x0003e; 0.1) (see Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Prolactin levels (mU/L) at T1 (baseline) and T2 (start of testing period)</bold>. Naltrexone significantly increased prolactin levels. Error bars indicate standard errors of the means.</p></caption><graphic xlink:href="fnbeh-07-00138-g0003"/></fig></sec><sec><title>Mood and cardiovascular measures</title><p>On the subjective mood ratings, there were no differences between treatment groups (i.e., the Treatment &#x000d7; Time interaction term) for Alertness [<italic>F</italic><sub>(4, 116)</sub> = 1.06, NS], Happiness [<italic>F</italic><sub>(4, 116)</sub> = 1.70, NS] or Calmness [<italic>F</italic><sub>(4, 116)</sub> = 0.09, NS]. Main effects of Time were observed on Alertness [<italic>F</italic><sub>(2, 116)</sub> = 23.10, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.29] and Happiness [<italic>F</italic><sub>(2, 116)</sub> = 7.26, <italic>p</italic> = 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.11], reflecting a general decrease over time across all groups.</p><p>On the cardiovascular measures, there were no differences between treatment groups (i.e., Treatment &#x000d7; Time interactions) on HR [<italic>F</italic><sub>(4, 116)</sub> = 1.07, NS], systolic BP [<italic>F</italic><sub>(3.3, 96.2)</sub> = 1.76, NS] or diastolic BP [<italic>F</italic><sub>(4, 116)</sub> = 1.65, NS]. Systolic BP and HR decreased over time across all groups [main effect of Time: <italic>F</italic><sub>(1.7, 96.2)</sub> = 3.92, <italic>p</italic> &#x0003c; 0.030, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.06; <italic>F</italic><sub>(2, 116)</sub> = 45.49, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.44, respectively].</p></sec><sec><title>Slot machine task</title><sec><title>Subjective effects of wins and near-misses</title><p>On the ratings of &#x0201c;pleased with outcome,&#x0201d; the omnibus ANOVA revealed a significant main effect of Outcome [<italic>F</italic><sub>(1.0, 59.0)</sub> = 189.66, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.77], such that participants were more pleased after wins compared to near-misses [<italic>t</italic><sub>(59)</sub> = 13.15, <italic>p</italic> &#x0003c; 0.001] and full-misses [<italic>t</italic><sub>(59)</sub> = 13.40, <italic>p</italic> &#x0003c; 0.001] (see Table <xref ref-type="table" rid="T2">2</xref>). Near misses were more pleasant than full misses [<italic>t</italic><sub>(59)</sub> = 2.19, <italic>p</italic> = 0.033]. An Outcome &#x000d7; Choice interaction was observed [<italic>F</italic><sub>(1.5, 84.0)</sub> = 4.32, <italic>p</italic> = 0.026, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.07], such that for near-misses and full-misses, participant-chosen outcomes were significantly less pleasant than computer-selected outcomes [<italic>t</italic><sub>(59)</sub> = 2.32, <italic>p</italic> = 0.024; <italic>t</italic><sub>(59)</sub> = 2.84, <italic>p</italic> = 0.006; respectively], whereas for wins, pleasantness ratings did not differ by choice condition [<italic>t</italic><sub>(59)</sub> = 1.46, <italic>p</italic> = 0.149]. An Outcome &#x000d7; Treatment interaction was observed [<italic>F</italic><sub>(2.1, 59.0)</sub> = 4.15, <italic>p</italic> = 0.020, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.13], driven by an effect of haloperidol [haloperidol model: <italic>F</italic><sub>(1.0, 39.1)</sub> = 6.56, <italic>p</italic> = 0.014, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.15; naltrexone model: <italic>F</italic><sub>(1.0, 38.6)</sub> = 0.85, NS]. The haloperidol group rated higher pleasure after wins [<italic>t</italic><sub>(38)</sub> = &#x02212;2.20, <italic>p</italic> = 0.034] and greater unpleasantness after non-wins [near-misses: <italic>t</italic><sub>(38)</sub> = 2.16, <italic>p</italic> = 0.038; full-misses: <italic>t</italic><sub>35.7</sub> = 2.36, <italic>p</italic> = 0.024] compared to the placebo group (see Table <xref ref-type="table" rid="T2">2</xref>). Thus, on a subjective rating, haloperidol appeared to potentiate both the positive affect to winning as well as negative affect following non-winning outcomes.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><bold>Subjective ratings on the slot machine task</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><bold>Placebo</bold></th><th align="left" rowspan="1" colspan="1"><bold>Haloperidol</bold></th><th align="left" rowspan="1" colspan="1"><bold>Naltrexone</bold></th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1"><bold>&#x0201c;CHANCES OF WINNING?&#x0201d;</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Participant</td><td align="char" char="." rowspan="1" colspan="1">38.8 (19.2)</td><td align="char" char="." rowspan="1" colspan="1">46.0 (17.9)</td><td align="char" char="." rowspan="1" colspan="1">40.9 (16.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Computer</td><td align="char" char="." rowspan="1" colspan="1">32.7 (16.7)</td><td align="char" char="." rowspan="1" colspan="1">36.7 (15.2)</td><td align="char" char="." rowspan="1" colspan="1">36.5 (15.2)</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>&#x0201c;PLEASED WITH RESULT?&#x0201d;</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Win, participant</td><td align="char" char="." rowspan="1" colspan="1">32.0 (31.3)</td><td align="char" char="." rowspan="1" colspan="1">56.6 (30.7)</td><td align="char" char="." rowspan="1" colspan="1">49.9 (27.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Win, computer</td><td align="char" char="." rowspan="1" colspan="1">34.1 (26.3)</td><td align="char" char="." rowspan="1" colspan="1">51.2 (35.5)</td><td align="char" char="." rowspan="1" colspan="1">43.4 (25.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;28.8 (21.2)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;49.9 (27.7)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;28.4 (19.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;29.2 (23.9)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;42.9 (28.4)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;24.9 (17.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;27.8 (20.1)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;47.2 (28.7)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;26.1 (18.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;26.4 (19.3)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;42.6 (27.9)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;21.8 (16.6)</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>&#x0201c;CONTINUE TO PLAY?&#x0201d;</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Win, participant</td><td align="char" char="." rowspan="1" colspan="1">51.8 (24.6)</td><td align="char" char="." rowspan="1" colspan="1">60.1 (23.1)</td><td align="char" char="." rowspan="1" colspan="1">62.3 (13.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Win, computer</td><td align="char" char="." rowspan="1" colspan="1">52.2 (24.4)</td><td align="char" char="." rowspan="1" colspan="1">62.5 (20.6)</td><td align="char" char="." rowspan="1" colspan="1">59.2 (12.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">45.2 (21.3)</td><td align="char" char="." rowspan="1" colspan="1">56.3 (19.8)</td><td align="char" char="." rowspan="1" colspan="1">53.6 (12.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">40.5 (24.7)</td><td align="char" char="." rowspan="1" colspan="1">51.4 (21.3)</td><td align="char" char="." rowspan="1" colspan="1">52.2 (11.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">42.2 (23.1)</td><td align="char" char="." rowspan="1" colspan="1">51.1 (22.9)</td><td align="char" char="." rowspan="1" colspan="1">52.3 (12.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">44.3 (21.9)</td><td align="char" char="." rowspan="1" colspan="1">53.3 (21.4)</td><td align="char" char="." rowspan="1" colspan="1">53.5 (11.4)</td></tr></tbody></table><table-wrap-foot><p>Values are reported as mean (SD), separated by the participant-chosen condition and the computer-chosen condition.</p></table-wrap-foot></table-wrap><p>On the rating of &#x0201c;continue to play,&#x0201d; the omnibus ANOVA revealed a significant main effect of Outcome [<italic>F</italic><sub>(1.2, 67.0)</sub> = 45.5, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.44], reflecting higher ratings after wins compared to non-wins [near-misses: <italic>t</italic><sub>(59)</sub> = 6.60, <italic>p</italic> &#x0003c; 0.001; full-misses: <italic>t</italic><sub>(59)</sub> = 7.53, <italic>p</italic> &#x0003c; 0.001]. There was an Outcome &#x000d7; Choice interaction [<italic>F</italic><sub>(2, 114)</sub> = 13.5, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.19]: the desire to play was higher after participant-chosen near-misses, compared to computer-chosen near-misses [<italic>t</italic><sub>(59)</sub> = 5.00, <italic>p</italic> &#x0003c; 0.001], and participant-chosen full-misses [<italic>t</italic><sub>(59)</sub> = 4.78, <italic>p</italic> &#x0003c; 0.001], as previously observed on this task (Clark et al., <xref ref-type="bibr" rid="B16">2009</xref>, <xref ref-type="bibr" rid="B14">2012a</xref>,<xref ref-type="bibr" rid="B15">b</xref>). There was also an Outcome &#x000d7; Choice &#x000d7; Treatment interaction [<italic>F</italic><sub>(4, 114)</sub> = 3.39, <italic>p</italic> = 0.012, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.11], driven by an effect of naltrexone [<italic>F</italic><sub>(2, 74)</sub> = 3.57, <italic>p</italic> = 0.033, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.09] [haloperidol model: <italic>F</italic><sub>(2, 76)</sub> = 0.42, NS]. In the placebo group, the participant-chosen near-misses were rated as more motivating than either computer-chosen near-misses [<italic>t</italic><sub>(18)</sub> = 3.27, <italic>p</italic> &#x0003c; 0.001] or participant-chosen full-misses [<italic>t</italic><sub>(18)</sub> = 3.66, <italic>p</italic> &#x0003c; 0.001]. These differences were not observed in the naltrexone group (all <italic>p</italic>s &#x0003e; 0.1) and the calculated difference score between participant-chosen and computer-chosen near-misses was marginally higher in the placebo group than in the naltrexone group [<italic>t</italic><sub>(37)</sub> = 1.80, <italic>p</italic> = 0.08]. Thus, naltrexone had a modest effect of attenuating the motivational ratings after self-selected near-misses (see Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Motivational ratings on the slot machine task showed an outcome (near-miss, full-miss) by control (participant-chosen, computer-chosen) interaction, whereby participant-chosen near-misses increased motivation to continue relative to the computer-chosen near-misses, in the placebo group (and haloperidol group), and this was attenuated in the naltrexone group</bold>. Error bars indicate standard error of the mean. <sup>*</sup><italic>p</italic> &#x0003c; 0.08.</p></caption><graphic xlink:href="fnbeh-07-00138-g0004"/></fig></sec><sec><title>Psychophysiological responses to wins and near-misses</title><p>For EDA max, there were significant main effects of Outcome [<italic>F</italic><sub>(1.4, 77.4)</sub> = 24.8, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.31] and Choice [<italic>F</italic><sub>(1, 56)</sub> = 28.0, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.33]. Across all groups, participants experienced higher EDA responses after wins compared to non-wins [near-misses: <italic>t</italic><sub>(58)</sub> = 5.42, <italic>p</italic> &#x0003c; 0.001; full-misses: <italic>t</italic><sub>(58)</sub> = 5.14, <italic>p</italic> &#x0003c; 0.001]. There was a marginal increase in EDA after near-misses in comparison to full-misses [<italic>t</italic><sub>(58)</sub> = 1.98, <italic>p</italic> = 0.053]. Participants showed higher EDA on participant-chosen outcomes compared to computer-chosen outcomes [wins: <italic>t</italic><sub>(58)</sub> = 2.06, <italic>p</italic> = 0.044; near-misses: <italic>t</italic><sub>(58)</sub> = 4.32, <italic>p</italic> &#x0003c; 0.001; full-misses: <italic>t</italic><sub>(58)</sub> = 2.72, <italic>p</italic> = 0.009]. There was a significant Outcome &#x000d7; Treatment interaction [<italic>F</italic><sub>(2.8, 77.4)</sub> = 3.52, <italic>p</italic> = 0.022, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.11], which was driven by the naltrexone group [<italic>F</italic><sub>(1.4, 51.9)</sub> = 5.09, <italic>p</italic> = 0.018, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.12] [haloperidol model: <italic>F</italic><sub>(1.3, 46.0)</sub> = 0.15, NS]. The EDA change to wins relative to full-misses was greater in the naltrexone group than the placebo group [<italic>t</italic><sub>(37)</sub> = &#x02212;2.47, <italic>p</italic> = 0.018], as well as marginally higher for the near-miss vs. full-miss change score [<italic>t</italic><sub>(37)</sub> = &#x02212;1.80, <italic>p</italic> = 0.081] (see Figure <xref ref-type="fig" rid="F5">5A</xref>). Thus, naltrexone increased the physiological responsiveness to wins in comparison to full-misses (Table <xref ref-type="table" rid="T3">3</xref>).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Psychophysiological responses on the slot machine task: (A) Naltrexone significantly increased post-outcome EDA following wins compared to both non-win outcomes (collapsing across choice conditions)</bold>. <bold>(B)</bold> The naltrexone group displayed marginally elevated post-outcome HR deceleration following wins compared to non-wins (collapsing across choice conditions). Error bars indicate standard error of the mean.</p></caption><graphic xlink:href="fnbeh-07-00138-g0005"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><bold>Psychophysiological responses to outcomes on the slot machine task (change scores from baseline)</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><bold>Placebo</bold></th><th align="left" rowspan="1" colspan="1"><bold>Haloperidol</bold></th><th align="left" rowspan="1" colspan="1"><bold>Naltrexone</bold></th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1"><bold>EDA MAX</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Win, participant</td><td align="char" char="." rowspan="1" colspan="1">0.30 (0.23)</td><td align="char" char="." rowspan="1" colspan="1">0.20 (0.17)</td><td align="char" char="." rowspan="1" colspan="1">0.42 (0.42)</td></tr><tr><td align="left" rowspan="1" colspan="1">Win, computer</td><td align="char" char="." rowspan="1" colspan="1">0.23 (0.22)</td><td align="char" char="." rowspan="1" colspan="1">0.18 (0.21)</td><td align="char" char="." rowspan="1" colspan="1">0.36 (0.44)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">0.22 (0.19)</td><td align="char" char="." rowspan="1" colspan="1">0.13 (0.14)</td><td align="char" char="." rowspan="1" colspan="1">0.25 (0.30)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">0.15 (0.18)</td><td align="char" char="." rowspan="1" colspan="1">0.07 (0.12)</td><td align="char" char="." rowspan="1" colspan="1">0.17 (0.30)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">0.21 (0.17)</td><td align="char" char="." rowspan="1" colspan="1">0.10 (0.11)</td><td align="char" char="." rowspan="1" colspan="1">0.16 (0.21)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">0.16 (0.13)</td><td align="char" char="." rowspan="1" colspan="1">0.7 (0.10)</td><td align="char" char="." rowspan="1" colspan="1">0.11 (0.15)</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>HR DECELERATION</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Win, participant</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;2.4 (1.8)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.6 (2.2)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;4.7 (3.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Win, computer</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.4 (2.9)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.4 (2.0)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;4.4 (4.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.0 (1.9)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.6 (1.6)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.9 (2.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;2.8 (2.0)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.7 (1.4)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.8 (3.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;2.7 (1.4)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;2.9 (1.0)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.2 (2.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.0 (2.0)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;2.8 (1.3)</td><td align="char" char="." rowspan="1" colspan="1">&#x02212;3.3 (2.5)</td></tr><tr><td align="left" colspan="4" rowspan="1"><bold>HR ACCELERATION</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Win, participant</td><td align="char" char="." rowspan="1" colspan="1">5.8 (3.6)</td><td align="char" char="." rowspan="1" colspan="1">6.1 (3.2)</td><td align="char" char="." rowspan="1" colspan="1">7.3 (4.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Win, computer</td><td align="char" char="." rowspan="1" colspan="1">5.0 (2.9)</td><td align="char" char="." rowspan="1" colspan="1">5.6 (3.4)</td><td align="char" char="." rowspan="1" colspan="1">6.2 (5.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">6.1 (2.7)</td><td align="char" char="." rowspan="1" colspan="1">6.5 (2.9)</td><td align="char" char="." rowspan="1" colspan="1">7.1 (5.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Near-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">5.8 (2.3)</td><td align="char" char="." rowspan="1" colspan="1">6.9 (3.5)</td><td align="char" char="." rowspan="1" colspan="1">7.5 (5.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, participant</td><td align="char" char="." rowspan="1" colspan="1">5.7 (2.4)</td><td align="char" char="." rowspan="1" colspan="1">6.1 (3.3)</td><td align="char" char="." rowspan="1" colspan="1">6.4 (5.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Full-miss, computer</td><td align="char" char="." rowspan="1" colspan="1">4.9 (1.8)</td><td align="char" char="." rowspan="1" colspan="1">5.3 (2.5)</td><td align="char" char="." rowspan="1" colspan="1">5.7 (4.1)</td></tr></tbody></table><table-wrap-foot><p>Values are reported as mean (SD), separated by participant-chosen condition and the computer-chosen condition. EDA, electrodermal activity, in &#x003bc;S, where the Max refers to the maximum value across bin 2&#x02013;4 (i.e., 2&#x02013;8 s post-outcome) minus the pre-trial baseline. HR, heart rate, in beats per minute, where the Deceleration value refers to the minimum value in bins 1&#x02013;6 (i.e., 0&#x02013;3 s post-outcome) minus the baseline; and the subsequent HR acceleration component refers to the maximum in bins 7&#x02013;12 (i.e., 3&#x02013;6 s post-outcome) minus the deceleration minima.</p></table-wrap-foot></table-wrap><p>On HR deceleration, there was a main effect of Outcome [<italic>F</italic><sub>(2, 106)</sub> = 6.44, <italic>p</italic> = 0.002, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.11], with greater HR decelerations after wins and near-misses in comparison to full-misses [<italic>t</italic><sub>(55)</sub> = &#x02212;3.23, <italic>p</italic> = 0.002; <italic>t</italic><sub>(55)</sub> = &#x02212;3.03, <italic>p</italic> = 0.004; respectively]. A trend Outcome &#x000d7; Treatment interaction was observed [<italic>F</italic><sub>(4, 106)</sub> = 2.11, <italic>p</italic> = 0.085, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.074], driven by an effect of naltrexone [<italic>F</italic><sub>(2, 70)</sub> = 2.86, <italic>p</italic> = 0.064, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.08] [haloperidol model: <italic>F</italic><sub>(2, 68)</sub> = 1.64, NS]. The HR deceleration to wins relative to full-misses was greater in the naltrexone group than the placebo group [<italic>t</italic><sub>(35)</sub> = 2.17, <italic>p</italic> = 0.03] (see Figure <xref ref-type="fig" rid="F5">5B</xref>), similar to the EDA effect. For HR acceleration, there was a significant effect of Outcome [<italic>F</italic><sub>(1.8, 93.4)</sub> = 8.12, <italic>p</italic> = 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.13], reflecting higher HR acceleration after near-misses relative to wins [<italic>t</italic><sub>(55)</sub> = 2.45, <italic>p</italic> = 0.018] and full-misses [<italic>t</italic><sub>(55)</sub> = 4.99, <italic>p</italic> &#x0003c; 0.001]. There was also a main effect of Choice [<italic>F</italic><sub>(1, 53)</sub> = 4.17, <italic>p</italic> = 0.046, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.07], indicating higher HR acceleration for participant-chosen outcomes compared to computer-chosen outcomes [wins: <italic>t</italic><sub>(55)</sub> = 2.02, <italic>p</italic> = 0.048; full-misses: <italic>t</italic><sub>(55)</sub> = 2.89, <italic>p</italic> = 0.006]. The HR acceleration effects did not interact with Treatment group.</p></sec><sec><title>Subjective effects of personal choice (the illusion of control)</title><p>On the ratings of &#x0201c;chances of winning,&#x0201d; participants reported a greater expectancy of winning when they chose the play icon, compared to the computer-chosen condition [<italic>F</italic><sub>(1, 57)</sub> = 44.59, <italic>p</italic> &#x0003c; 0.001, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.44]. This effect did not vary across treatment groups [Treatment &#x000d7; Choice: <italic>F</italic><sub>(2, 57)</sub> = 2.19, NS; Treatment: <italic>F</italic><sub>(2, 57)</sub> = 0.59, NS] (see Table <xref ref-type="table" rid="T2">2</xref>).</p></sec></sec><sec><title>Roulette task</title><sec><title>Gambler's fallacy</title><p>The analysis of color choice yielded a main effect of Run Length [<italic>F</italic><sub>(1, 55)</sub> = 7.84, <italic>p</italic> = 0.007, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.13], reflecting decreased choice of choosing either color after a longer run of that color (<italic>M</italic> = 43.1, <italic>SD</italic> = 23.6) compared to a short run (<italic>M</italic> = 50.9, <italic>SD</italic> = 9.5). This represents a typical Gambler's fallacy pattern. Treatment group did not moderate this effect [Run Length &#x000d7; Treatment: <italic>F</italic><sub>(2, 55)</sub> = 1.07, NS; Treatment: <italic>F</italic><sub>(2, 55)</sub> = 0.74, NS].</p></sec><sec><title>Hot hand belief</title><p>Analysis of confidence ratings as a function of feedback streak showed a weak effect of Outcome [<italic>F</italic><sub>(1, 55)</sub> = 3.34, <italic>p</italic> = 0.073, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.06], whereby confidence was higher after correct predictions compared to incorrect predictions, in line with the hot hand belief. The Streak Length &#x000d7; Outcome &#x000d7; Treatment interaction approached significance [<italic>F</italic><sub>(2, 55)</sub> = 2.51, <italic>p</italic> = 0.091, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.08]. This effect was driven by the naltrexone group, in which a significant 3-way interaction [<italic>F</italic><sub>(1, 35)</sub> = 5.41, <italic>p</italic> = 0.026, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.13] and a trend Outcome &#x000d7; Treatment interaction [<italic>F</italic><sub>(1, 35)</sub> = 3.81, <italic>p</italic> = 0.059, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.10] were observed [haloperidol model: <italic>F</italic><sub>(1, 37)</sub> = 2.37, NS]. Analysing winning and losing streaks separately in the naltrexone model, the Streak Length &#x000d7; Treatment interaction approached significance for wins [<italic>F</italic><sub>(1, 35)</sub> = 3.43, <italic>p</italic> = 0.073, &#x003b7;<sup>2</sup><sub><italic>p</italic></sub> = 0.09], but not for losses [<italic>F</italic><sub>(1, 35)</sub> = 1.91, NS], such that the naltrexone group showed a greater increase in confidence on longer winning streaks, compared to placebo (see Figure <xref ref-type="fig" rid="F6">6</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Confidence ratings on the roulette task as a function of winning streak length show a marginal difference between the naltrexone and placebo groups</bold>. Error bars indicate standard error of the mean.</p></caption><graphic xlink:href="fnbeh-07-00138-g0006"/></fig></sec></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>In this study, we assessed the effects of the opioid antagonist naltrexone and the dopamine D2-receptor antagonist haloperidol on two gambling tasks in male recreational gamblers. A slot machine task was used to deliver near-miss outcomes, elicit perceptions of control, and to measure physiological responses to winning outcomes. A roulette task was used to study the impact of outcome runs and feedback streaks on choice behavior and confidence ratings, respectively. Collapsing across the three treatment groups, both tasks were reasonably successful at inducing these gambling phenomena. On the slot machine task, the jackpot wins were rated as pleasurable and increased the motivation to play, and the winning outcomes were also associated with increased EDA and HR deceleration, relative to the non-wins. Comparing near-misses to full-misses, we confirmed our previous results on this task, that motivation ratings were higher after near-misses, and this effect depended on personal choice over the gamble (Clark et al., <xref ref-type="bibr" rid="B16">2009</xref>, <xref ref-type="bibr" rid="B14">2012a</xref>). The perceived chances of winning were also higher on participant-chosen trials than computer-chosen trials, consistent with an illusion of control. Near-misses were associated with increased EDA and rebound HR acceleration, as we have described previously (Clark et al., <xref ref-type="bibr" rid="B14">2012a</xref>, <xref ref-type="bibr" rid="B17">2013</xref>). On the roulette task, there was an expected Gambler's Fallacy effect, such that the choice of either color decreased after long runs of that color (i.e., negative recency) (replicating Ayton and Fischer, <xref ref-type="bibr" rid="B2">2004</xref>). There was also a weaker effect of increased confidence after wins compared to losses, consistent with the &#x0201c;Hot Hand&#x0201d; belief (Ayton and Fischer, <xref ref-type="bibr" rid="B2">2004</xref>).</p><p>In terms of the pharmacological effects, several differences were observed between the treatment groups, although generally, these were not in line with our predictions. The three groups were demographically matched and did not differ significantly on impulsivity, a relevant personality trait, or level of gambling involvement (PGSI) or trait gambling cognitions (GRCS). Prolactin levels increased in the naltrexone-treated group, but did not differ significantly between the haloperidol group and the placebo group. This implies that the single low dose of naltrexone (50 mg) was functionally active, but that the 2 mg haloperidol dose may not have been. Indeed, on the two gambling tasks, the majority of the detected group differences were between the naltrexone and placebo groups: the naltrexone group had a greater physiological response to winning outcomes on the slot machine task, in terms of EDA (significant) and HR deceleration (marginally significant). On the roulette task, the naltrexone group showed marginally higher confidence ratings after winning streaks compared to the placebo group, indicating a possible enhancement of the hot hand effect. At the same time, the motivational effect of the near-misses on participant-chosen trials was significantly attenuated in the naltrexone group. By contrast, in the haloperidol group, the only observed effect was a greater disparity in pleasantness ratings between the win and non-win outcomes (i.e., a treatment by outcome interaction). Neither group showed differences in the effect of personal control on the slot machine task, or the Gambler's Fallacy on the roulette task.</p><sec><title>Effects of naltrexone on gambling behavior</title><p>Based upon the reported clinical efficacy of naltrexone in the treatment of pathological gambling (Kim et al., <xref ref-type="bibr" rid="B46">2001</xref>; Grant et al., <xref ref-type="bibr" rid="B38">2006</xref>, <xref ref-type="bibr" rid="B37">2008</xref>), our overarching hypothesis for the naltrexone group was that cognitive effects characteristic of excessive gambling would be ameliorated by naltrexone. In addition, we predicted that these participants would show blunted responses to wins (c.f. Petrovic et al., <xref ref-type="bibr" rid="B76">2008</xref>). Our data indicated that naltrexone did modulate the responsivity to wins, but in the opposite direction to that predicted: the naltrexone group displayed <italic>higher</italic> EDA following wins, and this hyper-reactivity was substantiated by a trend effect for HR deceleration. <italic>Prima facie</italic>, these results are difficult to reconcile with the substantial literature reporting that opioid blockade reduces reward processing in laboratory models (Drewnowski et al., <xref ref-type="bibr" rid="B26">1995</xref>; Zhu et al., <xref ref-type="bibr" rid="B102">2011</xref>; Langleben et al., <xref ref-type="bibr" rid="B52">2012a</xref>), and reduces cravings and drug self-administration in groups with substance use disorders (Davidson et al., <xref ref-type="bibr" rid="B21">1999</xref>; Drobes et al., <xref ref-type="bibr" rid="B27">2004</xref>; Myrick et al., <xref ref-type="bibr" rid="B68">2008</xref>; Langleben et al., <xref ref-type="bibr" rid="B53">2012b</xref>; Miranda et al., <xref ref-type="bibr" rid="B64">2013</xref>).</p><p>A number of methodological differences may be pertinent here, and may be useful to inform the design of future experiments. A key point is that our participants were recreational gamblers with modest levels of gambling involvement; it is possible that pathological gamblers may show a qualitatively different response to opioid blockade. Our decision to use recreational gamblers was based on several factors: the ease of recruitment to achieve sufficient group sizes, ethical considerations about the use of gambling simulations in individuals with disordered gambling, and evidence that gambling severity is dimensional (Toce-Gerstein et al., <xref ref-type="bibr" rid="B91">2003</xref>). However, within the context of substance addictions (namely alcohol dependence), the response to naltrexone is known to vary as a function of genetics (the OPRM1 polymorphism) (Ray and Hutchison, <xref ref-type="bibr" rid="B81">2007</xref>) and family history of alcoholism (Krishnan-Sarin et al., <xref ref-type="bibr" rid="B48">2007</xref>). Family history of alcoholism is also a predictor of a positive treatment response to naltrexone in pathological gamblers (Grant et al., <xref ref-type="bibr" rid="B37">2008</xref>). In the study by Krishnan-Sarin et al. (<xref ref-type="bibr" rid="B48">2007</xref>), while naltrexone acted to decrease drinks consumed in a laboratory test in heavy drinkers with a family history of alcoholism, naltrexone actually <italic>increased</italic> drinking in those who were family history negative, similar to the effects observed here. The authors speculated that this effect may have been linked to individual difference in kappa-opioid action, which increase alcohol consumption in a rodent model (Mitchell et al., <xref ref-type="bibr" rid="B65">2005</xref>).</p><p>In the most comparable study to the present experiment, Petrovic et al. (<xref ref-type="bibr" rid="B76">2008</xref>) found reduced brain responses to winning outcomes following opioid blockade in healthy participants, coupled with greater activation to monetary losses. However, the Petrovic et al. (<xref ref-type="bibr" rid="B76">2008</xref>) study (and also Drewnowski et al., <xref ref-type="bibr" rid="B26">1995</xref>) used naloxone rather than naltrexone, and delivered intravenously rather than orally. The more rapid changes in brain concentrations associated with intravenous injection as opposed to oral dosing may cause divergent effects on behavior, as in the case of methylphenidate (Volkow and Swanson, <xref ref-type="bibr" rid="B92">2003</xref>). Naltrexone may also exert partial agonism effects (Ignar et al., <xref ref-type="bibr" rid="B41">2011</xref>), and along with naloxone and nalmefene, it is only moderately selective for the &#x003bc;-opioid receptor, which may modify its effects on reward seeking behavior (Giuliano et al., <xref ref-type="bibr" rid="B35">2012</xref>). As a third notable difference, the majority of past work in clinical groups has employed either subchronic (e.g. 7 day) dosing (e.g., Davidson et al., <xref ref-type="bibr" rid="B21">1999</xref>; Drobes et al., <xref ref-type="bibr" rid="B27">2004</xref>; Myrick et al., <xref ref-type="bibr" rid="B68">2008</xref>) or slow-release depot formulations (Langleben et al., <xref ref-type="bibr" rid="B52">2012a</xref>). Compensatory effects can occur in single-dose designs; for example, single dose citalopram treatment in healthy volunteers induced an impairment in reversal learning that was comparable to (rather than opposite to) effects observed in patients with major depression (Chamberlain et al., <xref ref-type="bibr" rid="B11">2006</xref>). Nevertheless, the single administration of naltrexone used in the present study was seen to increase plasma prolactin levels, replicating Shaw and Al'Absi (<xref ref-type="bibr" rid="B86">2010</xref>). Given that prolactin release is inhibited by hypothalamic dopamine transmission (Freeman et al., <xref ref-type="bibr" rid="B32">2000</xref>), a prolactin rise is presumed to reflect downstream dopamine blockade, indicative of overall opioid down-regulation.</p><p>In terms of the other gambling distortions under study, our findings were mixed. Consistent with the increased responsivity to wins, there was also an indication of enhanced confidence after winning streaks (i.e., increased &#x0201c;hot hand&#x0201d; effect). However, the motivational effects of near-miss outcomes were blunted in the naltrexone group. Given that the naltrexone effect on near-misses was restricted to a subjective rating (&#x0201c;continue to play&#x0201d;) and did not generalize to the psychophysiological measures, this result should be treated with caution. Moreover, the naltrexone group did not differ from placebo on two cardinal gambling distortions, the Gambler's Fallacy (on the roulette task) and the illusion of control (the manipulation of personal choice on the slot machine task), despite the fact that these distortions were robustly elicited in the overall study group. Related to the possibility that pathological gamblers may show a distinctive response to naltrexone, it is also conceivable that pathological and recreational gamblers may differ in their responses to gambling effects like near-misses (Habib and Dixon, <xref ref-type="bibr" rid="B39">2010</xref>) or illusory control (Orgaz et al., <xref ref-type="bibr" rid="B72">2013</xref>).</p></sec><sec><title>Effects of haloperidol on gambling behavior</title><p>Prior research has shown that the stimulation of dopamine transmission can induce (Voon et al., <xref ref-type="bibr" rid="B93">2009</xref>) and exacerbate (Zack and Poulos, <xref ref-type="bibr" rid="B98">2004</xref>) gambling tendencies, as well as specific distortions including the sense of agency (relevant to the illusion of control) (Moore et al., <xref ref-type="bibr" rid="B67">2010</xref>) and the behavioral response to near-misses (Winstanley et al., <xref ref-type="bibr" rid="B96">2011</xref>). There is some evidence that these effects are D2-receptor specific (Zack and Poulos, <xref ref-type="bibr" rid="B99">2007</xref>; Weintraub et al., <xref ref-type="bibr" rid="B95">2010</xref>; Winstanley et al., <xref ref-type="bibr" rid="B96">2011</xref>). Based on the argument by Frank and O'Reilly (<xref ref-type="bibr" rid="B31">2006</xref>) that lower doses of dopamine D2 receptor antagonists act preferentially on presynaptic D2 auto-receptors to <italic>increase</italic> dopamine transmission (see also Zack and Poulos, <xref ref-type="bibr" rid="B99">2007</xref>), we predicted that low dose haloperidol would enhance the reactivity to win and near-miss outcomes on the slot machine task, and increase the influence of personal choice. We found limited support for these predictions, and haloperidol showed few effects in this study. The only statistically significant difference from the placebo group was on the pleasantness ratings on the slot machine task, where the haloperidol group showed increased pleasantness ratings after wins and increased ratings of unpleasantness after non-win outcomes. This effect was not corroborated by any change in physiological reactivity under haloperidol. It should also be noted that collapsing across treatment groups, the pleasantness ratings varied significantly as a function of personal choice (i.e., an Outcome &#x000d7; Choice interaction), but no 3-way interaction was evident with treatment group. We infer that the haloperidol group may have been more extreme in their affective ratings, but that this may not constitute a genuine drug action.</p><p>Notably, the lack of any observed effect of haloperidol on prolactin levels raises the possibility that the 2 mg dosage may not have been functionally active. In the study by Frank and O'Reilly, 2 mg haloperidol significantly increased prolactin levels in a cross-over design. While we note that our post-dose plasma sample was obtained slightly earlier (at 2.5 h) than the expected peak (at 3 h in Darby et al., <xref ref-type="bibr" rid="B20">1995</xref>; at 4 h in Frank and O'Reilly, <xref ref-type="bibr" rid="B31">2006</xref>), we also observed no cardiovascular or mood effects, unlike past reports (Zack and Poulos, <xref ref-type="bibr" rid="B99">2007</xref>; Pine et al., <xref ref-type="bibr" rid="B78">2010</xref>). A number of other studies have employed low doses of haloperidol (1&#x02013;3 mg) in 3-arm studies that have included a group treated with the dopamine precursor levodopa (Pessiglione et al., <xref ref-type="bibr" rid="B75">2006</xref>; Pleger et al., <xref ref-type="bibr" rid="B79">2009</xref>; Pine et al., <xref ref-type="bibr" rid="B78">2010</xref>; Oei et al., <xref ref-type="bibr" rid="B71">2012</xref>). These studies have generally succeeded in demonstrating linear effects (i.e., haloperidol &#x0003c; placebo &#x0003c; levodopa) on reinforcement-related parameters, although in several instances, the specific haloperidol vs. placebo contrast was either non-significant (Pine et al., <xref ref-type="bibr" rid="B78">2010</xref>), or not reported (Pessiglione et al., <xref ref-type="bibr" rid="B75">2006</xref>; Oei et al., <xref ref-type="bibr" rid="B71">2012</xref>). Of course, based upon the argument of presynaptic upregulation, an intermediate dose may exist where the presynaptic and post-synaptic actions cancel each other out. It is also recognized that both phasic and tonic components of dopamine signaling are implicated in reward-driven behavior, and that a presynaptic manipulation may primarily affect phasic firing (Grace, <xref ref-type="bibr" rid="B36">1991</xref>; Niv et al., <xref ref-type="bibr" rid="B69">2007</xref>). Overall, we find limited evidence for functional effects of the 2 mg dose, and the absence of a significant prolactin response is particularly concerning; we recommend that future studies in healthy participants opt for higher doses &#x02265;3 mg.</p></sec><sec><title>Limitations and conclusion</title><p>This study was the first to assess the effects of an opioid antagonist, naltrexone, and a dopamine D2-receptor antagonist, haloperidol, on gambling tendencies. The indications of increased gambling proclivity following naltrexone (increased physiological reactivity to wins, increasing confidence ratings on winning streaks) are at odds with the reported clinical efficacy of naltrexone in pathological gambling, although the non-clinical study population and single dose administration design necessarily limit any direct comparison. As a strength of the study, the two tasks were successful at inducing the key cognitive distortions of interest in the overall study group. While the group comparisons involved no correction for the multiple dependent variables (hence risk of Type I error), we sought to corroborate effects on behavioral measures and subjective ratings with the acquisition of event-related psychophysiology, which successfully demonstrated significant EDA and HR reactivity to wins and near-misses. We opted to use a 3-arm, parallel-groups design, because our tasks were not known to be suitable for repeated testing, although this decision had several consequences. First, the direct comparisons involved non-independent tests against the same placebo group, and some of the specific gambling effects (HR deceleration to wins, the hot hand effect) were not selectively evident in the placebo group. In addition, between-groups analysis limits any examination of individual differences in drug responses; for example whether dopamine or opioid effects varied with age or trait impulsivity (Zack and Poulos, <xref ref-type="bibr" rid="B100">2009</xref>). As further limitations, we acknowledge that laboratory-based gambling simulations entail some compromises to ecological validity (Gainsbury and Blaszczynski, <xref ref-type="bibr" rid="B33">2011</xref>). While our slot machine task delivered real monetary wins, which is important for establishing physiological arousal (Ladouceur et al., <xref ref-type="bibr" rid="B49">2003</xref>), our tasks did not involve a variable wager. With regard to the limited effects of haloperidol on the gambling tasks, we highlight the non-significant change in prolactin as an indication that our low dose may not have achieved functional effectiveness, and as such, the null effects for haloperidol on the gambling tasks may say little about the relevance of dopamine signaling pathways to the neurobiology of gambling or the treatment potential of dopaminergic medications. However, the observed actions of naltrexone substantiate the relevance of opioid transmission to human decision-making and reinforcement processing, with treatment implications for a range of addictive and impulse control- related disorders.</p></sec><sec><title>Conflict of interest statement</title><p>Luke Clark is a consultant for Cambridge Cognition Ltd. Ulrich M&#x000fc;ller has been a consultant for Janssen Cilag and Eli-Lilly; he has received travel expenses and honoraria from the British Association for Psychopharmacology (BAP), Janssen Cilag, Eli-Lilly, Shire, UCB Pharma and the UK Adult ADHD Network (UKAAN) for talks at scientific and educational meetings. The other co-authors have no financial disclosures.</p></sec></sec></body><back><ack><p>The study was supported by research grants from the Royal Society (RG62223; 2010/R2), the University of Cambridge Isaac Newton Trust (10.44) and the Medical Research Council (G1100554). Roseline Porchet received a PhD studentship from the Behavioral and Clinical Neuroscience Institute (director TW Robbins), supported by a consortium award from the Medical Research Council and the Wellcome Trust. The study was run at the Wellcome Trust Clinical Research Facility at Addenbrooke's Hospital, Cambridge, and we are grateful to the nursing staff at the WTCRF for their assistance.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akitsuki</surname><given-names>Y.</given-names></name><name><surname>Sugiura</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>J.</given-names></name><name><surname>Yamashita</surname><given-names>K.</given-names></name><name><surname>Sassa</surname><given-names>Y.</given-names></name><name><surname>Awata</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Context-dependent cortical activation in response to financial reward and penalty: an event-related fMRI study</article-title>. <source>Neuroimage</source>
<volume>19</volume>, <fpage>1674</fpage>&#x02013;<lpage>1685</lpage>
<pub-id pub-id-type="doi">10.1016/S1053-8119(03)00250-7</pub-id><pub-id pub-id-type="pmid">12948722</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayton</surname><given-names>P.</given-names></name><name><surname>Fischer</surname><given-names>I.</given-names></name></person-group> (<year>2004</year>). <article-title>The hot hand fallacy and the gambler's fallacy: two faces of subjective randomness?</article-title>
<source>Mem. Cogn</source>. <volume>32</volume>, <fpage>1369</fpage>&#x02013;<lpage>1378</lpage>
<pub-id pub-id-type="doi">10.3758/BF03206327</pub-id><pub-id pub-id-type="pmid">15900930</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbano</surname><given-names>M. F.</given-names></name><name><surname>Cador</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Opioids for hedonic experience and dopamine to get ready for it</article-title>. <source>Psychopharmacology</source>
<volume>191</volume>, <fpage>497</fpage>&#x02013;<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-006-0521-1</pub-id><pub-id pub-id-type="pmid">17031710</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Jonathan</surname><given-names>N.</given-names></name><name><surname>Hnasko</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Dopamine as a prolactin (PRL) inhibitor</article-title>. <source>Endocr. Rev</source>. <volume>22</volume>, <fpage>724</fpage>&#x02013;<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1210/er.22.6.724</pub-id><pub-id pub-id-type="pmid">11739329</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergh</surname><given-names>C.</given-names></name><name><surname>Eklund</surname><given-names>T.</given-names></name><name><surname>Sodersten</surname><given-names>P.</given-names></name><name><surname>Nordin</surname><given-names>C.</given-names></name></person-group> (<year>1997</year>). <article-title>Altered dopamine function in pathological gambling</article-title>. <source>Psychol. Med</source>. <volume>27</volume>, <fpage>473</fpage>&#x02013;<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291796003789</pub-id><pub-id pub-id-type="pmid">9089839</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billieux</surname><given-names>J.</given-names></name><name><surname>van der Linden</surname><given-names>M.</given-names></name><name><surname>Khazaal</surname><given-names>Y.</given-names></name><name><surname>Zullino</surname><given-names>D.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Trait gambling cognitions predict near-miss experiences and persistence in laboratory slot machine gambling</article-title>. <source>Br. J. Psychol</source>. <volume>103</volume>, <fpage>412</fpage>&#x02013;<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1111/j.2044-8295.2011.02083.x</pub-id><pub-id pub-id-type="pmid">22804705</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bland</surname><given-names>R. C.</given-names></name><name><surname>Newman</surname><given-names>S. C.</given-names></name><name><surname>Orn</surname><given-names>H.</given-names></name><name><surname>Stebelsky</surname><given-names>G.</given-names></name></person-group> (<year>1993</year>). <article-title>Epidemiology of pathological gambling in Edmonton</article-title>. <source>Can. J. Psychiatry</source>
<volume>38</volume>, <fpage>108</fpage>&#x02013;<lpage>112</lpage>
<pub-id pub-id-type="pmid">8467435</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boettiger</surname><given-names>C. A.</given-names></name><name><surname>Kelley</surname><given-names>E. A.</given-names></name><name><surname>Mitchell</surname><given-names>J. M.</given-names></name><name><surname>D'Esposito</surname><given-names>M.</given-names></name><name><surname>Fields</surname><given-names>H. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network</article-title>. <source>Pharmacol. Biochem. Behav</source>. <volume>93</volume>, <fpage>291</fpage>&#x02013;<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2009.02.008</pub-id><pub-id pub-id-type="pmid">19258022</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>A.</given-names></name><name><surname>Lader</surname><given-names>M.</given-names></name></person-group> (<year>1974</year>). <article-title>The use of analogue scales in rating subjective feelings</article-title>. <source>Br. J. Psychol</source>. <volume>47</volume>, <fpage>211</fpage>&#x02013;<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1111/j.2044-8341.1974.tb02285.x</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>M. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Emotion and Motivation</article-title>, in <source>Handbook of Psychophysiology 2nd Edn.</source>, eds <person-group person-group-type="editor"><name><surname>Cacioppo</surname><given-names>J. T.</given-names></name><name><surname>Tassinary</surname><given-names>L. G.</given-names></name><name><surname>Berntson</surname><given-names>G. G.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>), <fpage>602</fpage>&#x02013;<lpage>642</lpage></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cardinal</surname><given-names>R. N.</given-names></name><name><surname>Aitken</surname><given-names>M. R. F.</given-names></name></person-group> (<year>2006</year>). <source>ANOVA for the Behavioural Sciences Researcher</source>. <publisher-loc>New Jersey</publisher-loc>: <publisher-name>Lawrence Erlbaum Associates</publisher-name></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>S. R.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>U.</given-names></name><name><surname>Blackwell</surname><given-names>A. D.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Robbins</surname><given-names>T. W.</given-names></name><name><surname>Sahakian</surname><given-names>B. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Neurochemical modulation of response inhibition and probabilistic learning in humans</article-title>. <source>Science</source>
<volume>311</volume>, <fpage>861</fpage>&#x02013;<lpage>863</lpage>
<pub-id pub-id-type="doi">10.1126/science.1121218</pub-id><pub-id pub-id-type="pmid">16469930</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chase</surname><given-names>H. W.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Gambling severity predicts midbrain response to near-miss outcomes</article-title>. <source>J. Neurosci</source>. <volume>30</volume>, <fpage>6180</fpage>&#x02013;<lpage>6187</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5758-09.2010</pub-id><pub-id pub-id-type="pmid">20445043</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Decision-making during gambling: an integration of cognitive and psychobiological approaches</article-title>. <source>Philos. Trans. R. Soc. Lond. B Biol. Sci</source>. <volume>365</volume>, <fpage>319</fpage>&#x02013;<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2009.0147</pub-id><pub-id pub-id-type="pmid">20026469</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Crooks</surname><given-names>B.</given-names></name><name><surname>Clarke</surname><given-names>R.</given-names></name><name><surname>Aitken</surname><given-names>M. R.</given-names></name><name><surname>Dunn</surname><given-names>B. D.</given-names></name></person-group> (<year>2012a</year>). <article-title>Physiological responses to near-miss outcomes and personal control during simulated gambling</article-title>. <source>J. Gambl. Stud</source>. <volume>28</volume>, <fpage>123</fpage>&#x02013;<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1007/s10899-011-9247-z</pub-id><pub-id pub-id-type="pmid">21516368</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Wright</surname><given-names>C. M.</given-names></name><name><surname>Rome</surname><given-names>F.</given-names></name><name><surname>Fairchild</surname><given-names>G.</given-names></name><name><surname>Dunn</surname><given-names>B. D.</given-names></name><etal/></person-group> (<year>2012b</year>). <article-title>Risk-avoidant decision making increased by threat of electric shock</article-title>. <source>Psychophysiology</source>
<volume>49</volume>, <fpage>1436</fpage>&#x02013;<lpage>1443</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8986.2012.01454.x</pub-id><pub-id pub-id-type="pmid">22913418</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Lawrence</surname><given-names>A. J.</given-names></name><name><surname>Astley-Jones</surname><given-names>F.</given-names></name><name><surname>Gray</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry</article-title>. <source>Neuron</source>
<volume>61</volume>, <fpage>481</fpage>&#x02013;<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2008.12.031</pub-id><pub-id pub-id-type="pmid">19217383</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>McKavanagh</surname><given-names>R.</given-names></name><name><surname>Garrett</surname><given-names>A.</given-names></name><name><surname>Dunn</surname><given-names>B. D.</given-names></name><name><surname>Aitken</surname><given-names>M. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Learning and affect following near-miss outcomes in simulated gambling</article-title>. <source>J. Behav. Dec. Making</source>. <pub-id pub-id-type="doi">10.1002/bdm.1774</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coricelli</surname><given-names>G.</given-names></name><name><surname>Critchley</surname><given-names>H. D.</given-names></name><name><surname>Joffily</surname><given-names>M.</given-names></name><name><surname>O'Doherty</surname><given-names>J. P.</given-names></name><name><surname>Sirigu</surname><given-names>A.</given-names></name><name><surname>Dolan</surname><given-names>R. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Regret and its avoidance: a neuroimaging study of choice behavior</article-title>. <source>Nat. Neurosci</source>. <volume>8</volume>, <fpage>1255</fpage>&#x02013;<lpage>1262</lpage>
<pub-id pub-id-type="doi">10.1038/nn1514</pub-id><pub-id pub-id-type="pmid">16116457</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crabtree</surname><given-names>B. L.</given-names></name></person-group> (<year>1984</year>). <article-title>Review of naltrexone, a long-acting opiate antagonist</article-title>. <source>Clin. Pharm</source>. <volume>3</volume>, <fpage>273</fpage>&#x02013;<lpage>280</lpage>
<pub-id pub-id-type="pmid">6329589</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cyders</surname><given-names>M. A.</given-names></name><name><surname>Smith</surname><given-names>G. T.</given-names></name><name><surname>Spillane</surname><given-names>N. S.</given-names></name><name><surname>Fischer</surname><given-names>S.</given-names></name><name><surname>Annus</surname><given-names>A. M.</given-names></name><name><surname>Peterson</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Integration of impulsivity and positive mood to predict risky behavior: development and validation of a measure of positive urgency</article-title>. <source>Psychol. Assess</source>. <volume>19</volume>, <fpage>107</fpage>&#x02013;<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1037/1040-3590.19.1.107</pub-id><pub-id pub-id-type="pmid">17371126</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darby</surname><given-names>J. K.</given-names></name><name><surname>Pasta</surname><given-names>D. J.</given-names></name><name><surname>Dabiri</surname><given-names>L.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Mosbacher</surname><given-names>D.</given-names></name></person-group> (<year>1995</year>). <article-title>Haloperidol dose and blood level variability: toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting</article-title>. <source>J. Clin. Psychopharmacol</source>. <volume>15</volume>, <fpage>334</fpage>&#x02013;<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1097/00004714-199510000-00005</pub-id><pub-id pub-id-type="pmid">8830064</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>D.</given-names></name><name><surname>Palfai</surname><given-names>T.</given-names></name><name><surname>Bird</surname><given-names>C.</given-names></name><name><surname>Swift</surname><given-names>R.</given-names></name></person-group> (<year>1999</year>). <article-title>Effects of naltrexone on alcohol self-administration in heavy drinkers</article-title>. <source>Alc. Clin. Exp. Res</source>. <volume>23</volume>, <fpage>195</fpage>&#x02013;<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1111/j.1530-0277.1999.tb04099.x</pub-id><pub-id pub-id-type="pmid">10069545</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>M. E.</given-names></name><name><surname>Schell</surname><given-names>A. M.</given-names></name><name><surname>Filion</surname><given-names>D. L.</given-names></name></person-group> (<year>2000</year>). <article-title>The electrodermal system</article-title>, in <source>Handbook of Psychophysiology, 2nd Edn.</source>, eds <person-group person-group-type="editor"><name><surname>Cacioppo</surname><given-names>J. T.</given-names></name><name><surname>Tassinary</surname><given-names>L. G.</given-names></name><name><surname>Berntson</surname><given-names>G. G.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>), <fpage>200</fpage>&#x02013;<lpage>223</lpage></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Declerck</surname><given-names>C. H.</given-names></name><name><surname>Boone</surname><given-names>C.</given-names></name><name><surname>De Brabander</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>On feeling in control: a biological theory for individual differences in control perception</article-title>. <source>Brain Cogn</source>. <volume>62</volume>, <fpage>143</fpage>&#x02013;<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.bandc.2006.04.004</pub-id><pub-id pub-id-type="pmid">16806623</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>M. J.</given-names></name><name><surname>Harrigan</surname><given-names>K. A.</given-names></name><name><surname>Jarick</surname><given-names>M.</given-names></name><name><surname>Maclaren</surname><given-names>V.</given-names></name><name><surname>Fugelsang</surname><given-names>J. A.</given-names></name><name><surname>Sheepy</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Psychophysiological arousal signatures of near-misses in slot machine play</article-title>. <source>Int. Gamb. Stud</source>. <volume>11</volume>, <fpage>1</fpage>&#x02013;<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1080/14459795.2011.603134</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djamshidian</surname><given-names>A.</given-names></name><name><surname>Cardoso</surname><given-names>F.</given-names></name><name><surname>Grosset</surname><given-names>D.</given-names></name><name><surname>Bowden-Jones</surname><given-names>H.</given-names></name><name><surname>Lees</surname><given-names>A. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Pathological gambling in Parkinson's disease&#x02013;a review of the literature</article-title>. <source>Mov. Disord</source>. <volume>26</volume>, <fpage>1976</fpage>&#x02013;<lpage>1984</lpage>
<pub-id pub-id-type="doi">10.1002/mds.23821</pub-id><pub-id pub-id-type="pmid">21661054</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drewnowski</surname><given-names>A.</given-names></name><name><surname>Krahn</surname><given-names>D. D.</given-names></name><name><surname>Demitrack</surname><given-names>M. A.</given-names></name><name><surname>Nairn</surname><given-names>K.</given-names></name><name><surname>Gosnell</surname><given-names>B. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters</article-title>. <source>Am. J. Clin. Nutr</source>. <volume>61</volume>, <fpage>1206</fpage>&#x02013;<lpage>1212</lpage>
<pub-id pub-id-type="pmid">7762518</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drobes</surname><given-names>D. J.</given-names></name><name><surname>Anton</surname><given-names>R. F.</given-names></name><name><surname>Thomas</surname><given-names>S. E.</given-names></name><name><surname>Voronin</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers</article-title>. <source>Alc. Clin. Exp. Res</source>. <volume>28</volume>, <fpage>1362</fpage>&#x02013;<lpage>1370</lpage>
<pub-id pub-id-type="doi">10.1097/01.ALC.0000139704.88862.01</pub-id><pub-id pub-id-type="pmid">15365307</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>R.</given-names></name><name><surname>Friston</surname><given-names>K. J.</given-names></name><name><surname>Dolan</surname><given-names>R. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Dissociable neural responses in human reward systems</article-title>. <source>J. Neurosci</source>. <volume>20</volume>, <fpage>6159</fpage>&#x02013;<lpage>6165</lpage>
<pub-id pub-id-type="pmid">10934265</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emond</surname><given-names>M. S.</given-names></name><name><surname>Marmurek</surname><given-names>H. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Gambling related cognitions mediate the association between thinking style and problem gambling severity</article-title>. <source>J. Gambl. Stud</source>. <volume>26</volume>, <fpage>257</fpage>&#x02013;<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1007/s10899-009-9164-6</pub-id><pub-id pub-id-type="pmid">19943091</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ferris</surname><given-names>J.</given-names></name><name><surname>Wynne</surname><given-names>H.</given-names></name></person-group> (<year>2001</year>). <source>Canadian Problem Gambling Index</source>. <publisher-loc>Ottawa, Ontario</publisher-loc>: <publisher-name>Canadian Centre on Substance Abuse</publisher-name></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortune</surname><given-names>E. E.</given-names></name><name><surname>Goodie</surname><given-names>A. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Cognitive distortions as a component and treatment focus of pathological gambling: a review</article-title>. <source>Psychol. Addict. Behav</source>. <volume>2012</volume>, <fpage>298</fpage>&#x02013;<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1037/a0026422</pub-id><pub-id pub-id-type="pmid">22121918</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>M. J.</given-names></name><name><surname>O'Reilly</surname><given-names>R. C.</given-names></name></person-group> (<year>2006</year>). <article-title>A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol</article-title>. <source>Behav. Neurosci</source>. <volume>120</volume>, <fpage>497</fpage>&#x02013;<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.120.3.497</pub-id><pub-id pub-id-type="pmid">16768602</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>M. E.</given-names></name><name><surname>Kanyicska</surname><given-names>B.</given-names></name><name><surname>Lerant</surname><given-names>A.</given-names></name><name><surname>Nagy</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Prolactin: structure, function, and regulation of secretion</article-title>. <source>Physiol. Rev</source>. <volume>80</volume>, <fpage>1523</fpage>&#x02013;<lpage>1631</lpage>
<pub-id pub-id-type="pmid">11015620</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gainsbury</surname><given-names>S.</given-names></name><name><surname>Blaszczynski</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The appropriateness of using laboratories and student participants in gambling research</article-title>. <source>J. Gambl. Stud</source>. <volume>27</volume>, <fpage>83</fpage>&#x02013;<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1007/s10899-010-9190-4</pub-id><pub-id pub-id-type="pmid">20372997</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilovich</surname><given-names>T.</given-names></name><name><surname>Vallone</surname><given-names>R.</given-names></name><name><surname>Tversky</surname><given-names>A.</given-names></name></person-group> (<year>1985</year>). <article-title>The hot hand in basketball: on the misperception of random sequences</article-title>. <source>Cognit. Psychol</source>. <volume>17</volume>, <fpage>295</fpage>&#x02013;<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1016/0010-0285(85)90010-6</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuliano</surname><given-names>C.</given-names></name><name><surname>Robbins</surname><given-names>T. W.</given-names></name><name><surname>Nathan</surname><given-names>P. J.</given-names></name><name><surname>Bullmore</surname><given-names>E. T.</given-names></name><name><surname>Everitt</surname><given-names>B. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating</article-title>. <source>Neuropsychopharmacology</source>
<volume>37</volume>, <fpage>2643</fpage>&#x02013;<lpage>2652</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2012.128</pub-id><pub-id pub-id-type="pmid">22805601</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname><given-names>A. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia</article-title>. <source>Neuroscience</source>
<volume>41</volume>, <fpage>1</fpage>&#x02013;<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(91)90196-U</pub-id><pub-id pub-id-type="pmid">1676137</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>J. E.</given-names></name><name><surname>Kim</surname><given-names>S. W.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Potenza</surname><given-names>M. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Predicting response to opiate antagonists and placebo in the treatment of pathological gambling</article-title>. <source>Psychopharmacology</source>
<volume>200</volume>, <fpage>521</fpage>&#x02013;<lpage>527</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-008-1235-3</pub-id><pub-id pub-id-type="pmid">18581096</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>J. E.</given-names></name><name><surname>Potenza</surname><given-names>M. N.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Cunningham-Williams</surname><given-names>R.</given-names></name><name><surname>Nurminen</surname><given-names>T.</given-names></name><name><surname>Smits</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling</article-title>. <source>Am. J. Psychiatry</source>
<volume>163</volume>, <fpage>303</fpage>&#x02013;<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.163.2.303</pub-id><pub-id pub-id-type="pmid">16449486</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>R.</given-names></name><name><surname>Dixon</surname><given-names>M. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Neurobehavioral evidence for the &#x0201c;Near-Miss&#x0201d; effect in pathological gamblers</article-title>. <source>J. Exp. Anal. Behav</source>. <volume>93</volume>, <fpage>313</fpage>&#x02013;<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1901/jeab.2010.93-313</pub-id><pub-id pub-id-type="pmid">21119848</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodes</surname><given-names>R. L.</given-names></name><name><surname>Cook</surname><given-names>E. W.</given-names><suffix>3rd.</suffix></name><name><surname>Lang</surname><given-names>P. J.</given-names></name></person-group> (<year>1985</year>). <article-title>Individual differences in autonomic response: conditioned association or conditioned fear?</article-title>
<source>Psychophysiology</source>
<volume>22</volume>, <fpage>545</fpage>&#x02013;<lpage>560</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8986.1985.tb01649.x</pub-id><pub-id pub-id-type="pmid">4048355</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignar</surname><given-names>D. M.</given-names></name><name><surname>Goetz</surname><given-names>A. S.</given-names></name><name><surname>Noble</surname><given-names>K. N.</given-names></name><name><surname>Carballo</surname><given-names>L. H.</given-names></name><name><surname>Stroup</surname><given-names>A. E.</given-names></name><name><surname>Fisher</surname><given-names>J. C.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist</article-title>. <source>J. Pharmacol. Exp. Ther</source>. <volume>339</volume>, <fpage>24</fpage>&#x02013;<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1124/jpet.111.180943</pub-id><pub-id pub-id-type="pmid">21712426</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joutsa</surname><given-names>J.</given-names></name><name><surname>Johansson</surname><given-names>J.</given-names></name><name><surname>Niemela</surname><given-names>S.</given-names></name><name><surname>Ollikainen</surname><given-names>A.</given-names></name><name><surname>Hirvonen</surname><given-names>M. M.</given-names></name><name><surname>Piepponen</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Mesolimbic dopamine release is linked to symptom severity in pathological gambling</article-title>. <source>Neuroimage</source>
<volume>60</volume>, <fpage>1992</fpage>&#x02013;<lpage>1999</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.02.006</pub-id><pub-id pub-id-type="pmid">22348881</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname><given-names>S.</given-names></name><name><surname>Remington</surname><given-names>G.</given-names></name><name><surname>Jones</surname><given-names>C.</given-names></name><name><surname>Wilson</surname><given-names>A.</given-names></name><name><surname>DaSilva</surname><given-names>J.</given-names></name><name><surname>Houle</surname><given-names>S.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study</article-title>. <source>Am. J. Psychiatry</source>
<volume>153</volume>, <fpage>948</fpage>&#x02013;<lpage>950</lpage>
<pub-id pub-id-type="pmid">8659621</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassinove</surname><given-names>J. I.</given-names></name><name><surname>Schare</surname><given-names>M. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Effects of the &#x0201c;near miss&#x0201d; and the &#x0201c;big win&#x0201d; on persistence at slot machine gambling</article-title>. <source>Psychol. Addict. Behav</source>. <volume>15</volume>, <fpage>155</fpage>&#x02013;<lpage>158</lpage>
<pub-id pub-id-type="doi">10.1037/0893-164X.15.2.155</pub-id><pub-id pub-id-type="pmid">11419232</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzen-Perez</surname><given-names>K. R.</given-names></name><name><surname>Jacobs</surname><given-names>D. W.</given-names></name><name><surname>Lincoln</surname><given-names>A.</given-names></name><name><surname>Ellis</surname><given-names>R. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Opioid blockade improves human recognition memory following physiological arousal</article-title>. <source>Pharmacol. Biochem. Behav</source>. <volume>70</volume>, <fpage>77</fpage>&#x02013;<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1016/S0091-3057(01)00589-5</pub-id><pub-id pub-id-type="pmid">11566144</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. W.</given-names></name><name><surname>Grant</surname><given-names>J. E.</given-names></name><name><surname>Adson</surname><given-names>D. E.</given-names></name><name><surname>Shin</surname><given-names>Y. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling</article-title>. <source>Biol. Psychiatry</source>
<volume>49</volume>, <fpage>914</fpage>&#x02013;<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(01)01079-4</pub-id><pub-id pub-id-type="pmid">11377409</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreek</surname><given-names>M. J.</given-names></name></person-group> (<year>1996</year>). <article-title>Opiates, opioids and addiction</article-title>. <source>Mol. Psychiatry</source>
<volume>1</volume>, <fpage>232</fpage>&#x02013;<lpage>254</lpage>
<pub-id pub-id-type="pmid">9118348</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan-Sarin</surname><given-names>S.</given-names></name><name><surname>Krystal</surname><given-names>J. H.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Pittman</surname><given-names>B.</given-names></name><name><surname>O'Malley</surname><given-names>S. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking</article-title>. <source>Biol. Psychiatry</source>
<volume>62</volume>, <fpage>694</fpage>&#x02013;<lpage>697</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.11.018</pub-id><pub-id pub-id-type="pmid">17336941</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladouceur</surname><given-names>R.</given-names></name><name><surname>Sevigny</surname><given-names>S.</given-names></name><name><surname>Blaszczynski</surname><given-names>A.</given-names></name><name><surname>O'Connor</surname><given-names>K.</given-names></name><name><surname>Lavoie</surname><given-names>M. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Video lottery: winning expectancies and arousal</article-title>. <source>Addiction</source>
<volume>98</volume>, <fpage>733</fpage>&#x02013;<lpage>738</lpage>
<pub-id pub-id-type="doi">10.1046/j.1360-0443.2003.00412.x</pub-id><pub-id pub-id-type="pmid">12780361</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ladouceur</surname><given-names>R.</given-names></name><name><surname>Walker</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>A cognitive perspective on gambling</article-title>, in <source>Trends in Cognitive and Behavioural Therapies</source>, eds <person-group person-group-type="editor"><name><surname>Salkovskis</surname><given-names>P. M.</given-names></name></person-group> (<publisher-loc>Chichester</publisher-loc>: <publisher-name>Wiley and Sons</publisher-name>), <fpage>89</fpage>&#x02013;<lpage>120</lpage></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langer</surname><given-names>E. J.</given-names></name></person-group> (<year>1975</year>). <article-title>The illusion of control</article-title>. <source>J. Pers. Soc. Psychol</source>. <volume>32</volume>, <fpage>311</fpage>&#x02013;<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1037/0022-3514.32.2.311</pub-id><pub-id pub-id-type="pmid">16634679</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langleben</surname><given-names>D. D.</given-names></name><name><surname>Busch</surname><given-names>E. L.</given-names></name><name><surname>O'Brien</surname><given-names>C. P.</given-names></name><name><surname>Elman</surname><given-names>I.</given-names></name></person-group> (<year>2012a</year>). <article-title>Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence</article-title>. <source>Psychopharmacology</source>
<volume>220</volume>, <fpage>559</fpage>&#x02013;<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-011-2503-1</pub-id><pub-id pub-id-type="pmid">21960180</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langleben</surname><given-names>D. D.</given-names></name><name><surname>Ruparel</surname><given-names>K.</given-names></name><name><surname>Elman</surname><given-names>I.</given-names></name><name><surname>Loughead</surname><given-names>J. W.</given-names></name><name><surname>Busch</surname><given-names>E. L.</given-names></name><name><surname>Cornish</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012b</year>). <article-title>Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients</article-title>. <source>Addict. Biol</source>. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/j.1369-1600.2012.00462.x</pub-id><pub-id pub-id-type="pmid">22747521</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeman</surname><given-names>R. F.</given-names></name><name><surname>Potenza</surname><given-names>M. N.</given-names></name></person-group> (<year>2012</year>). <article-title>Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity</article-title>. <source>Psychopharmacology</source>
<volume>219</volume>, <fpage>469</fpage>&#x02013;<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-011-2550-7</pub-id><pub-id pub-id-type="pmid">22057662</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limbrick-Oldfield</surname><given-names>E. H.</given-names></name><name><surname>Van Holst</surname><given-names>R. J.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Fronto-striatal dysregulation in drug addiction and pathological gambling: consistent inconsistencies?</article-title>
<source>Neuroimage Clin</source>. <volume>2</volume>, <fpage>385</fpage>&#x02013;<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1016/j.nicl.2013.02.005</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linnet</surname><given-names>J.</given-names></name><name><surname>Moller</surname><given-names>A.</given-names></name><name><surname>Peterson</surname><given-names>E.</given-names></name><name><surname>Gjedde</surname><given-names>A.</given-names></name><name><surname>Doudet</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling</article-title>. <source>Addiction</source>
<volume>106</volume>, <fpage>383</fpage>&#x02013;<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.03126.x</pub-id><pub-id pub-id-type="pmid">20883460</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo</surname><given-names>D. S.</given-names></name><name><surname>Kennedy</surname><given-names>J. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities</article-title>. <source>Addiction</source>
<volume>104</volume>, <fpage>1454</fpage>&#x02013;<lpage>1465</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2009.02671.x</pub-id><pub-id pub-id-type="pmid">19686516</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lole</surname><given-names>L.</given-names></name><name><surname>Gonsalvez</surname><given-names>C. J.</given-names></name><name><surname>Blaszczynski</surname><given-names>A.</given-names></name><name><surname>Clarke</surname><given-names>A. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Electrodermal activity reliably captures physiological differences between wins and losses during gambling on electronic machines</article-title>. <source>Psychophysiology</source>
<volume>49</volume>, <fpage>154</fpage>&#x02013;<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8986.2011.01290.x</pub-id><pub-id pub-id-type="pmid">22091782</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Soelch</surname><given-names>C.</given-names></name><name><surname>Szczepanik</surname><given-names>J.</given-names></name><name><surname>Nugent</surname><given-names>A.</given-names></name><name><surname>Barhaghi</surname><given-names>K.</given-names></name><name><surname>Rallis</surname><given-names>D.</given-names></name><name><surname>Herscovitch</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum</article-title>. <source>Eur. J. Neurosci</source>. <volume>33</volume>, <fpage>1706</fpage>&#x02013;<lpage>1715</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07642.x</pub-id><pub-id pub-id-type="pmid">21453423</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>G.</given-names></name><name><surname>Schwertfeger</surname><given-names>J.</given-names></name><name><surname>Exton</surname><given-names>M. S.</given-names></name><name><surname>Janssen</surname><given-names>O. E.</given-names></name><name><surname>Knapp</surname><given-names>W.</given-names></name><name><surname>Stadler</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Neuroendocrine response to casino gambling in problem gamblers</article-title>. <source>Psychoneuroendocrinology</source>
<volume>29</volume>, <fpage>1272</fpage>&#x02013;<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2004.03.005</pub-id><pub-id pub-id-type="pmid">15288706</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M. C.</given-names></name><name><surname>Straughn</surname><given-names>A. B.</given-names></name><name><surname>Lo</surname><given-names>M. W.</given-names></name><name><surname>Schary</surname><given-names>W. L.</given-names></name><name><surname>Whitney</surname><given-names>C. C.</given-names></name></person-group> (<year>1984</year>). <article-title>Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration</article-title>. <source>J. Clin. Psychiatry</source>
<volume>45</volume>, <fpage>15</fpage>&#x02013;<lpage>19</lpage>
<pub-id pub-id-type="pmid">6469932</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalczuk</surname><given-names>R.</given-names></name><name><surname>Bowden-Jones</surname><given-names>H.</given-names></name><name><surname>Verdejo-Garcia</surname><given-names>A.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Impulsivity and cognitive distortions in pathological gamblers attending the UK National Problem Gambling Clinic: a preliminary report</article-title>. <source>Psychol. Med</source>. <volume>41</volume>, <fpage>2625</fpage>&#x02013;<lpage>2635</lpage>
<pub-id pub-id-type="doi">10.1017/S003329171100095X</pub-id><pub-id pub-id-type="pmid">21733207</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>N. V.</given-names></name><name><surname>Currie</surname><given-names>S. R.</given-names></name></person-group> (<year>2008</year>). <article-title>A Canadian population level analysis of the roles of irrational gambling cognitions and risky gambling practices as correlates of gambling intensity and pathological gambling</article-title>. <source>J. Gambl. Stud</source>. <volume>24</volume>, <fpage>257</fpage>&#x02013;<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1007/s10899-008-9089-5</pub-id><pub-id pub-id-type="pmid">18256906</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>R.</given-names></name><name><surname>Ray</surname><given-names>L.</given-names></name><name><surname>Blanchard</surname><given-names>A.</given-names></name><name><surname>Reynolds</surname><given-names>E. K.</given-names></name><name><surname>Monti</surname><given-names>P. M.</given-names></name><name><surname>Chun</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial</article-title>. <source>Addict. Biol</source>. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/adb.12050</pub-id><pub-id pub-id-type="pmid">23489253</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>J. M.</given-names></name><name><surname>Liang</surname><given-names>M. T.</given-names></name><name><surname>Fields</surname><given-names>H. L.</given-names></name></person-group> (<year>2005</year>). <article-title>A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats</article-title>. <source>Psychopharmacology</source>
<volume>182</volume>, <fpage>384</fpage>&#x02013;<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-005-0067-7</pub-id><pub-id pub-id-type="pmid">16001119</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>J. M.</given-names></name><name><surname>Tavares</surname><given-names>V. C.</given-names></name><name><surname>Fields</surname><given-names>H. L.</given-names></name><name><surname>D'Esposito</surname><given-names>M.</given-names></name><name><surname>Boettiger</surname><given-names>C. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls</article-title>. <source>Neuropsychopharmacology</source>
<volume>32</volume>, <fpage>439</fpage>&#x02013;<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301226</pub-id><pub-id pub-id-type="pmid">17047667</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>J. W.</given-names></name><name><surname>Schneider</surname><given-names>S. A.</given-names></name><name><surname>Schwingenschuh</surname><given-names>P.</given-names></name><name><surname>Moretto</surname><given-names>G.</given-names></name><name><surname>Bhatia</surname><given-names>K. P.</given-names></name><name><surname>Haggard</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Dopaminergic medication boosts action-effect binding in Parkinson's disease</article-title>. <source>Neuropsychologia</source>
<volume>48</volume>, <fpage>1125</fpage>&#x02013;<lpage>1132</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2009.12.014</pub-id><pub-id pub-id-type="pmid">20018200</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myrick</surname><given-names>H.</given-names></name><name><surname>Anton</surname><given-names>R. F.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Henderson</surname><given-names>S.</given-names></name><name><surname>Randall</surname><given-names>P. K.</given-names></name><name><surname>Voronin</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>65</volume>, <fpage>466</fpage>&#x02013;<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.65.4.466</pub-id><pub-id pub-id-type="pmid">18391135</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niv</surname><given-names>Y.</given-names></name><name><surname>Daw</surname><given-names>N. D.</given-names></name><name><surname>Joel</surname><given-names>D.</given-names></name><name><surname>Dayan</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Tonic dopamine: opportunity costs and the control of response vigor</article-title>. <source>Psychopharmacology (Berl.)</source>
<volume>191</volume>, <fpage>507</fpage>&#x02013;<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-006-0502-4</pub-id><pub-id pub-id-type="pmid">17031711</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>C. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Anticraving medications for relapse prevention: a possible new class of psychoactive medications</article-title>. <source>Am. J. Psychiatry</source>
<volume>162</volume>, <fpage>1423</fpage>&#x02013;<lpage>1431</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.162.8.1423</pub-id><pub-id pub-id-type="pmid">16055763</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oei</surname><given-names>N. Y.</given-names></name><name><surname>Rombouts</surname><given-names>S. A.</given-names></name><name><surname>Soeter</surname><given-names>R. P.</given-names></name><name><surname>van Gerven</surname><given-names>J. M.</given-names></name><name><surname>Both</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Dopamine modulates reward system activity during subconscious processing of sexual stimuli</article-title>. <source>Neuropsychopharmacology</source>
<volume>37</volume>, <fpage>1729</fpage>&#x02013;<lpage>1737</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2012.19</pub-id><pub-id pub-id-type="pmid">22395731</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orgaz</surname><given-names>C.</given-names></name><name><surname>Estevez</surname><given-names>A.</given-names></name><name><surname>Matute</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Pathological gamblers are more vulnerable to the illusion of control in a standard associative learning task</article-title>. <source>Front. Psychol</source>. <volume>4</volume>:<issue>306</issue>
<pub-id pub-id-type="doi">10.3389/fpsyg.2013.00306</pub-id><pub-id pub-id-type="pmid">23785340</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oskarsson</surname><given-names>A. T.</given-names></name><name><surname>Van Boven</surname><given-names>L.</given-names></name><name><surname>McClelland</surname><given-names>G. H.</given-names></name><name><surname>Hastie</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>What's next? Judging sequences of binary events</article-title>. <source>Psychol. Bull</source>. <volume>135</volume>, <fpage>262</fpage>&#x02013;<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1037/a0014821</pub-id><pub-id pub-id-type="pmid">19254080</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecina</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>K. S.</given-names></name><name><surname>Berridge</surname><given-names>K. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Hedonic hot spots in the brain</article-title>. <source>Neuroscientist</source>
<volume>12</volume>, <fpage>500</fpage>&#x02013;<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1177/1073858406293154</pub-id><pub-id pub-id-type="pmid">17079516</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pessiglione</surname><given-names>M.</given-names></name><name><surname>Seymour</surname><given-names>B.</given-names></name><name><surname>Flandin</surname><given-names>G.</given-names></name><name><surname>Dolan</surname><given-names>R. J.</given-names></name><name><surname>Frith</surname><given-names>C. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Dopamine-dependent prediction errors underpin reward-seeking behavior in humans</article-title>. <source>Nature</source>
<volume>442</volume>, <fpage>1042</fpage>&#x02013;<lpage>1045</lpage>
<pub-id pub-id-type="doi">10.1038/nature05051</pub-id><pub-id pub-id-type="pmid">16929307</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrovic</surname><given-names>P.</given-names></name><name><surname>Pleger</surname><given-names>B.</given-names></name><name><surname>Seymour</surname><given-names>B.</given-names></name><name><surname>Kloppel</surname><given-names>S.</given-names></name><name><surname>De Martino</surname><given-names>B.</given-names></name><name><surname>Critchley</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses</article-title>. <source>J. Neurosci</source>. <volume>28</volume>, <fpage>10509</fpage>&#x02013;<lpage>10516</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2807-08.2008</pub-id><pub-id pub-id-type="pmid">18923027</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petry</surname><given-names>N. M.</given-names></name><name><surname>Blanco</surname><given-names>C.</given-names></name><name><surname>Auriacombe</surname><given-names>M.</given-names></name><name><surname>Borges</surname><given-names>G.</given-names></name><name><surname>Bucholz</surname><given-names>K.</given-names></name><name><surname>Crowley</surname><given-names>T. J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>An overview of and rationale for changes proposed for pathological gambling in DSM-5</article-title>. <source>J. Gambl. Stud</source>. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1007/s10899-013-9370-0</pub-id><pub-id pub-id-type="pmid">23526033</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pine</surname><given-names>A.</given-names></name><name><surname>Shiner</surname><given-names>T.</given-names></name><name><surname>Seymour</surname><given-names>B.</given-names></name><name><surname>Dolan</surname><given-names>R. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Dopamine, time, and impulsivity in humans</article-title>. <source>J. Neurosci</source>. <volume>30</volume>, <fpage>8888</fpage>&#x02013;<lpage>8896</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6028-09.2010</pub-id><pub-id pub-id-type="pmid">20592211</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleger</surname><given-names>B.</given-names></name><name><surname>Ruff</surname><given-names>C. C.</given-names></name><name><surname>Blankenburg</surname><given-names>F.</given-names></name><name><surname>Kloppel</surname><given-names>S.</given-names></name><name><surname>Driver</surname><given-names>J.</given-names></name><name><surname>Dolan</surname><given-names>R. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Influence of dopaminergically mediated reward on somatosensory decision-making</article-title>. <source>PLoS Biol</source>. <volume>7</volume>:<fpage>e1000164</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000164</pub-id><pub-id pub-id-type="pmid">19636360</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potenza</surname><given-names>M. N.</given-names></name></person-group> (<year>2008</year>). <article-title>The neurobiology of pathological gambling and drug addiction: an overview and new findings</article-title>. <source>Philos. Trans. R. Soc. Lond. B Biol. Sci</source>. <volume>363</volume>, <fpage>3181</fpage>&#x02013;<lpage>3189</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2008.0100</pub-id><pub-id pub-id-type="pmid">18640909</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>L. A.</given-names></name><name><surname>Hutchison</surname><given-names>K. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>64</volume>, <fpage>1069</fpage>&#x02013;<lpage>1077</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.64.9.1069</pub-id><pub-id pub-id-type="pmid">17768272</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raylu</surname><given-names>N.</given-names></name><name><surname>Oei</surname><given-names>T. P.</given-names></name></person-group> (<year>2004</year>). <article-title>The Gambling Related Cognitions Scale (GRCS): development, confirmatory factor validation and psychometric properties</article-title>. <source>Addiction</source>
<volume>99</volume>, <fpage>757</fpage>&#x02013;<lpage>769</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2004.00753.x</pub-id><pub-id pub-id-type="pmid">15139874</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redgrave</surname><given-names>P.</given-names></name><name><surname>Gurney</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>The short-latency dopamine signal: a role in discovering novel actions?</article-title>
<source>Nat. Rev. Neurosci</source>. <volume>7</volume>, <fpage>967</fpage>&#x02013;<lpage>975</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2022</pub-id><pub-id pub-id-type="pmid">17115078</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>R. L.</given-names></name></person-group> (<year>1986</year>). <article-title>The psychology of the near miss</article-title>. <source>J. Gambl. Behav</source>. <volume>2</volume>, <fpage>32</fpage>&#x02013;<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1007/BF01019932</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname><given-names>H. J.</given-names></name><name><surname>Hall</surname><given-names>M. N.</given-names></name><name><surname>Vander Bilt</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis</article-title>. <source>Am. J. Public Health</source>
<volume>89</volume>, <fpage>1369</fpage>&#x02013;<lpage>1376</lpage>
<pub-id pub-id-type="doi">10.2105/AJPH.89.9.1369</pub-id><pub-id pub-id-type="pmid">10474555</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>D.</given-names></name><name><surname>Al'Absi</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Blunted opiate modulation of prolactin response in smoking men and women</article-title>. <source>Pharmacol. Biochem. Behav</source>. <volume>95</volume>, <fpage>1</fpage>&#x02013;<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2009.11.016</pub-id><pub-id pub-id-type="pmid">19969014</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>D. V.</given-names></name><name><surname>Lecrubier</surname><given-names>Y.</given-names></name><name><surname>Sheehan</surname><given-names>K. H.</given-names></name><name><surname>Amorim</surname><given-names>P.</given-names></name><name><surname>Janavs</surname><given-names>J.</given-names></name><name><surname>Weiller</surname><given-names>E.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source>J. Clin. Psychiatry</source>
<volume>59</volume><issue>Suppl. 20</issue>, <fpage>22</fpage>&#x02013;<lpage>33</lpage>
<pub-id pub-id-type="pmid">9881538</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spanagel</surname><given-names>R.</given-names></name><name><surname>Herz</surname><given-names>A.</given-names></name><name><surname>Shippenberg</surname><given-names>T. S.</given-names></name></person-group> (<year>1992</year>). <article-title>Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>89</volume>, <fpage>2046</fpage>&#x02013;<lpage>2050</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.89.6.2046</pub-id><pub-id pub-id-type="pmid">1347943</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steeves</surname><given-names>T. D.</given-names></name><name><surname>Miyasaki</surname><given-names>J.</given-names></name><name><surname>Zurowski</surname><given-names>M.</given-names></name><name><surname>Lang</surname><given-names>A. E.</given-names></name><name><surname>Pellecchia</surname><given-names>G.</given-names></name><name><surname>Van Eimeren</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study</article-title>. <source>Brain</source>
<volume>132</volume>, <fpage>1376</fpage>&#x02013;<lpage>1385</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awp054</pub-id><pub-id pub-id-type="pmid">19346328</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studer</surname><given-names>B.</given-names></name><name><surname>Apergis-Schoute</surname><given-names>A. M.</given-names></name><name><surname>Robbins</surname><given-names>T. W.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>What are the odds? The neural correlates of active choice during gambling</article-title>. <source>Front. Neurosci</source>. <volume>6</volume>:<issue>46</issue>
<pub-id pub-id-type="doi">10.3389/fnins.2012.00046</pub-id><pub-id pub-id-type="pmid">22529770</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studer</surname><given-names>B.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Place your bets: psychophysiological correlates of decision-making under risk</article-title>. <source>Cogn. Aff. Behav. Neurosci</source>. <volume>11</volume>, <fpage>144</fpage>&#x02013;<lpage>158</lpage>
<pub-id pub-id-type="doi">10.3758/s13415-011-0025-2</pub-id><pub-id pub-id-type="pmid">21380769</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toce-Gerstein</surname><given-names>M.</given-names></name><name><surname>Gerstein</surname><given-names>D. R.</given-names></name><name><surname>Volberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2003</year>). <article-title>A hierarchy of gambling disorders in the community</article-title>. <source>Addiction</source>
<volume>98</volume>, <fpage>1661</fpage>&#x02013;<lpage>1672</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2003.00545.x</pub-id><pub-id pub-id-type="pmid">14651495</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>N. D.</given-names></name><name><surname>Swanson</surname><given-names>J. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD</article-title>. <source>Am. J. Psychiatry</source>
<volume>160</volume>, <fpage>1909</fpage>&#x02013;<lpage>1918</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.160.11.1909</pub-id><pub-id pub-id-type="pmid">14594733</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voon</surname><given-names>V.</given-names></name><name><surname>Fernagut</surname><given-names>P. O.</given-names></name><name><surname>Wickens</surname><given-names>J.</given-names></name><name><surname>Baunez</surname><given-names>C.</given-names></name><name><surname>Rodriguez</surname><given-names>M.</given-names></name><name><surname>Pavon</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders</article-title>. <source>Lancet Neurol</source>. <volume>8</volume>, <fpage>1140</fpage>&#x02013;<lpage>1149</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(09)70287-X</pub-id><pub-id pub-id-type="pmid">19909912</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wardle</surname><given-names>H.</given-names></name><name><surname>Moody</surname><given-names>A.</given-names></name><name><surname>Spence</surname><given-names>S.</given-names></name><name><surname>Orford</surname><given-names>J.</given-names></name><name><surname>Volberg</surname><given-names>R.</given-names></name><name><surname>Jotangia</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2010</year>). <source>British Gambling Prevalence Survey</source>. <publisher-loc>London</publisher-loc>: <publisher-name>National Centre for Social Research</publisher-name></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>D.</given-names></name><name><surname>Koester</surname><given-names>J.</given-names></name><name><surname>Potenza</surname><given-names>M. N.</given-names></name><name><surname>Siderowf</surname><given-names>A. D.</given-names></name><name><surname>Stacy</surname><given-names>M.</given-names></name><name><surname>Voon</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients</article-title>. <source>Arch Neurol</source>
<volume>67</volume>, <fpage>589</fpage>&#x02013;<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2010.65</pub-id><pub-id pub-id-type="pmid">20457959</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winstanley</surname><given-names>C. A.</given-names></name><name><surname>Cocker</surname><given-names>P. J.</given-names></name><name><surname>Rogers</surname><given-names>R. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a &#x02018;near-miss&#x02019; effect</article-title>. <source>Neuropsychopharmacology</source>
<volume>36</volume>, <fpage>913</fpage>&#x02013;<lpage>925</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2010.230</pub-id><pub-id pub-id-type="pmid">21209612</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiberas</surname><given-names>X.</given-names></name><name><surname>Martinot</surname><given-names>J. L.</given-names></name><name><surname>Mallet</surname><given-names>L.</given-names></name><name><surname>Artiges</surname><given-names>E.</given-names></name><name><surname>Loc</surname><given-names>H. C.</given-names></name><name><surname>Maziere</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia</article-title>. <source>Br. J. Psychiatry</source>
<volume>179</volume>, <fpage>503</fpage>&#x02013;<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.179.6.503</pub-id><pub-id pub-id-type="pmid">11731352</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>M.</given-names></name><name><surname>Poulos</surname><given-names>C. X.</given-names></name></person-group> (<year>2004</year>). <article-title>Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers</article-title>. <source>Neuropsychopharmacology</source>
<volume>29</volume>, <fpage>195</fpage>&#x02013;<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300333</pub-id><pub-id pub-id-type="pmid">14571257</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>M.</given-names></name><name><surname>Poulos</surname><given-names>C. X.</given-names></name></person-group> (<year>2007</year>). <article-title>A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers</article-title>. <source>Neuropsychopharmacology</source>
<volume>32</volume>, <fpage>1678</fpage>&#x02013;<lpage>1686</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301295</pub-id><pub-id pub-id-type="pmid">17203013</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>M.</given-names></name><name><surname>Poulos</surname><given-names>C. X.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity</article-title>. <source>J. Psychopharmacol</source>. <volume>23</volume>, <fpage>660</fpage>&#x02013;<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1177/0269881108091072</pub-id><pub-id pub-id-type="pmid">18583430</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zald</surname><given-names>D. H.</given-names></name><name><surname>Boileau</surname><given-names>I.</given-names></name><name><surname>El-Dearedy</surname><given-names>W.</given-names></name><name><surname>Gunn</surname><given-names>R.</given-names></name><name><surname>McGlone</surname><given-names>F.</given-names></name><name><surname>Dichter</surname><given-names>G. S.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Dopamine transmission in the human striatum during monetary reward tasks</article-title>. <source>J. Neurosci</source>. <volume>24</volume>, <fpage>4105</fpage>&#x02013;<lpage>4112</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4643-03.2004</pub-id><pub-id pub-id-type="pmid">15115805</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Spencer</surname><given-names>T. J.</given-names></name><name><surname>Liu-Chen</surname><given-names>L. Y.</given-names></name><name><surname>Biederman</surname><given-names>J.</given-names></name><name><surname>Bhide</surname><given-names>P. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Methylphenidate and mu opioid receptor interactions: a pharmacological target for prevention of stimulant abuse</article-title>. <source>Neuropharmacology</source>
<volume>61</volume>, <fpage>283</fpage>&#x02013;<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.04.015</pub-id><pub-id pub-id-type="pmid">21545805</pub-id></mixed-citation></ref></ref-list></back></article>